<SEC-DOCUMENT>0001437749-22-028836.txt : 20221212
<SEC-HEADER>0001437749-22-028836.hdr.sgml : 20221212
<ACCEPTANCE-DATETIME>20221212090035
ACCESSION NUMBER:		0001437749-22-028836
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20221207
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221212
DATE AS OF CHANGE:		20221212

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEVA INC
		CENTRAL INDEX KEY:			0001173489
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
		IRS NUMBER:				770556376
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-49842
		FILM NUMBER:		221456321

	BUSINESS ADDRESS:	
		STREET 1:		15245 SHADY GROVE ROAD
		STREET 2:		SUITE 400
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		240-308-8328

	MAIL ADDRESS:	
		STREET 1:		15245 SHADY GROVE ROAD
		STREET 2:		SUITE 400
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CEVA  INC
		DATE OF NAME CHANGE:	20031208

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PARTHUSCEVA INC
		DATE OF NAME CHANGE:	20021101

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CEVA INC
		DATE OF NAME CHANGE:	20020515
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ceva20221209_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ceva="http://www.ceva.com/20221207"><head>
	<title>ceva20221209_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 12/10/2022 10:02:41 PM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20228K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20228K" name="dei:EntityCentralIndexKey">0001173489</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="ceva-20221207.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20228K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001173489</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-12-07</xbrli:startDate>
<xbrli:endDate>2022-12-07</xbrli:endDate>
</xbrli:period>
</xbrli:context>


</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0" />
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></div>

<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>WASHINGTON, DC 20549</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric contextRef="d20228K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Pursuant to Section 13 or 15(d) of the</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Securities Exchange Act of 1934</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Date of report (Date of earliest event reported): </b><ix:nonNumeric contextRef="d20228K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 7, 2022</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityRegistrantName"><b>CEVA, INC.</b></ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Exact Name of Registrant as Specified in Charter)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:18.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">&#xa0;</td>
			<td style="vertical-align:top;width:18.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityFileNumber">000-49842</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:bottom;width:1.1%;">&#xa0;</td>
			<td style="vertical-align:top;width:18.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityTaxIdentificationNumber">77-0556376</ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(State or Other Jurisdiction</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>of Incorporation)</b></div>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Commission</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>File Number)</b></div>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(I.R.S. Employer</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Identification No.)</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressAddressLine1"><b>15245 Shady Grove Road, Suite 400</b></ix:nonNumeric><b>, <ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressCityOrTown"><b>Rockville</b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressStateOrProvince"><b>MD</b></ix:nonNumeric> <ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressPostalZipCode"><b>20850</b></ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Address of Principal Executive Offices, and Zip Code)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(<ix:nonNumeric contextRef="d20228K" name="dei:CityAreaCode"><b>240</b></ix:nonNumeric>) <ix:nonNumeric contextRef="d20228K" name="dei:LocalPhoneNumber"><b>308-8328</b></ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Registrant</b>&#8217;<b>s Telephone Number, Including Area Code</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Former Name or Former Address, if Changed Since Last Report)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see</i> General Instruction A.2. below):</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: bottom; width: 18.1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Title of each class</div>
			</td>
			<td style="vertical-align:top;width:1.1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 18.1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Trading Symbol(s)</div>
			</td>
			<td style="vertical-align:top;width:1.1%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 18.1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Name of each exchange on which registered</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:Security12bTitle">Common Stock</ix:nonNumeric>, $0.001 par value</div>
			</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:TradingSymbol">CEVA</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The <ix:nonNumeric contextRef="d20228K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric> Stock Market LLC</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2 of this chapter).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">Emerging growth company <ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Departure of Executive Vice President of Worldwide Sales</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On December 7, 2022, the Board of Directors (the &#8220;Board&#8221;) of CEVA, Inc. (the &#8220;Company&#8221;) and Issachar Ohana, the Executive Vice President (&#8220;EVP&#8221;) of Worldwide Sales of the Company reached an understanding regarding his separation from the Company, and the Company and Mr. Ohana entered into a Separation and Release Agreement (the &#8220;Separation Agreement&#8221;) later that day pursuant to which Mr. Ohana&#8217;s last day of service as the EVP of Worldwide Sales of the Company will be December 31, 2022 (the &#8220;Separation Date&#8221;).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Pursuant to the Separation Agreement, in exchange for certain releases and waivers, the Company will provide Mr. Ohana the following benefits: (i) an amount equal to thirty days of his base salary in lieu of the notice required under his employment agreement with the Company dated November 1, 2002 (as amended, the &#8220;Employment Agreement&#8221;), payable on the Company&#8217;s first regular payroll date after the Separation Date; (ii) an amount equal to the base salary to which he would have been entitled had he remained employed with the Company for two years after the Separation Date (the &#8220;Severance Period&#8221;) as required under the Employment Agreement, payable in equal installments on the Company&#8217;s regular payroll dates and paid less all applicable deductions and withholdings; (iii) continuation of his benefits under the Company&#8217;s group health plans until the Separation Date, after which he will be eligible to continue his participation in the Company&#8217;s group health insurance plan under applicable COBRA regulations in which case the Company will pay the applicable COBRA premiums for Mr. Ohana and his covered dependents until the earliest of a) the two year anniversary of the Separation Date, b) the date he becomes eligible for health insurance coverage from a new employer or through self-employment, or c) the date he is no longer eligible to continue coverage under COBRA; (iv) an amount equal to any unpaid incentive compensation he would have been eligible to earn under the Company&#8217;s 2022 Incentive Bonus Plan (the &#8220;IB Plan&#8221;) for achievement of specified revenue targets through December 31, 2022, less applicable deductions and withholdings in accordance with the terms of the IB Plan; (v) an amount equal to two years of the largest 401(k) Plan contribution allowed as if Mr. Ohana was still employed by the Company based on his base salary immediately prior to the date of the Separation Agreement, to be paid in equal installments on the Company&#8217;s regular payroll dates over the duration of the Severance Period less any applicable deductions, withholdings, or taxes; and (vi) accelerated vesting of the certain time and performance-based restricted stock units ( &#8220;RSUs&#8221;) previously awarded to Mr. Ohana pursuant to the terms of the Company&#8217;s 2011 Equity Incentive Plan (as amended, the &#8220;Plan&#8221;), including to the extent applicable performance goals are achieved as determined by the Board or a committee thereof, vesting of such RSUs as of the date of determination of achievement of the performance goals.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The foregoing description of the Separation Agreement does not purport to be complete and is qualified in its entirety by reference to the complete text of the agreement, a copy of which has been attached as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Appointment of Chief Commercial Officer</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On December 7, 2022, the Company&#8217;s Board appointed Gweltaz Toquet, who currently serves as the Vice President of Sales for Europe and Asia Pacific, as Chief Commercial Officer (&#8220;CCO&#8221;) of the Company effective January 1, 2023 (the &#8220;Promotion Date&#8221;).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Mr. Toquet, 49, has more than 20 years of sales and management experience with the Company, most recently serving as the Company&#8217;s Vice President of Sales for Asia Pacific, India and Europe. In particular, Mr. Toquet has spent over 15 years as the Company&#8217;s Vice President of Sales for Asia Pacific based in Hong Kong, where he led the build-out and management of the sales and support functions in the region spanning China, Japan, Taiwan and Korea. Prior to joining the Company in 2002, Mr. Toquet held several roles in sales, business development, product marketing and business line management at Freehand DSP and Texas Instruments. Mr. Toquet holds a Master of Science in Engineering degree from Institut Sup&#233;rieur d&#8217;Electronique de Paris (ISEP).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On May 11, 2021, the Company entered into an employment agreement with Mr. Toquet in connection with his retention as the Vice President of Sales for the Asia Pacific region (the &#8220;Employment Agreement&#8221;). Under his Employment Agreement, Mr. Toquet is entitled to a salary of SEK 1,500,000 per year, and is eligible to participate in the Company&#8217;s annual target incentive bonus of SEK 1,500,000 as evaluated and paid out on a quarterly basis. Mr. Toquet is also eligible to participate in regular health insurance, pension, employee stock purchase plans and other employee benefit plans established by the Company for its employees from time to time. The Employment Agreement also contains customary provisions relating to, among other things, employee duties and representations, exclusivity and non-competition.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On December 7, 2022, the Company and Mr. Toquet entered into an addendum (the &#8220;Addendum&#8221;) to the Employment Agreement. The Addendum, effective as of the Promotion Date, provides for the following in addition to and in variation of the Employment Agreement: (i) Mr. Toquet&#8217;s appointment as the Company&#8217;s CCO, with responsibilities and reporting duties as set forth in the Addendum and Employment Agreement; (ii) an increase in Mr. Toquet&#8217;s annual salary to SEK 2,320,000; (iii) Mr. Toquet&#8217;s entitlement to participate in the Company&#8217;s commission plan in the amount of SEK 1,750,000 per annum, as well as the Company&#8217;s Officers&#8217; Equity Plan; (iv) the grant of RSUs pursuant to the Plan to be approved by the Compensation Committee of the Board, effective on the Promotion Date, with value equal to $100,000, one-third of which will vest on each anniversary of the Promotion Date, conditioned upon Mr. Toquet&#8217;s continued service with the Company; (v) to incorporate a notice requirement such that should Mr. Toquet desire to terminate his employment with the Company, he is requested to provide the Company with six months&#8217; prior written notice to the Company, and conversely, should the Company desire to terminate Mr. Toquet&#8217;s employment without Cause (as defined in the Addendum), the Company must provide Mr. Toquet with six months&#8217; prior written notice, unless the Company pays Mr. Toquet a sum equal to the salary that he would otherwise be entitled to during such period; (vi) if Mr. Toquet resigns for Good Reason (as defined in the Addendum), the Company shall pay him a sum equal to the salary that he would otherwise be entitled to during the six month period from the date of delivery of the resignation notice; (vii) the Company may terminate Mr. Toquet&#8217;s employment for Cause without advance notice and without derogating from any remedy to which the Company may be entitled; (viii) if, within twelve months after a Change in Control (as defined in the Addendum), Mr. Toquet terminates his employment with the Company for Good Reason or the Company terminates his employment without Cause, he will receive pay in an amount equal to the compensation to which he would otherwise have been entitled to had he remained employed by the Company for one year after such termination, based on his salary in effect on the date of termination, and all outstanding and unvested time-based equity awards granted by the Company to Mr. Toquet will fully vest; and (ix) the promotion and other remuneration terms under the Addendum are contingent on Mr. Toquet&#8217;s execution of a non-disclosure, non-compete and assignment of ideas agreement as of the Promotion Date. The benefits provided for in connection with a Change in Control are subject to Mr. Toquet&#8217;s delivery of a release of claims in a form reasonably acceptable to the Company.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The foregoing descriptions of the Addendum and Employment Agreement do not purport to be complete and are qualified in their entirety by reference to the complete text of the agreements, copies of which are attached as Exhibit 10.2 and 10.3 to this Current Report on Form 8-K and incorporated herein by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">There are no arrangements or understandings between Mr. Toquet and any other person pursuant to which Mr. Toquet was appointed to serve as CCO of the Company. There are no family relationships between Mr. Toquet and any director or executive officer of the Company, and Mr. Toquet does not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A copy of the Company&#8217;s press release with respect to the matters addressed in this Item 5.02 is attached as Exhibit 99.1 to this Current Report on Form 8-K.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 9.01. Financial Statements and Exhibits. </b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(d) Exhibits.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 10.6%; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Exhibit</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number</b></div>
			</td>
			<td style="vertical-align:top;width:2.4%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Description</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.1*</div>
			</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_455177.htm" style="-sec-extract:exhibit;">Separation and Release Agreement, dated December 7, 2022, between CEVA Development, Inc. and Issachar Ohana</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.2*</div>
			</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_455178.htm" style="-sec-extract:exhibit;">Addendum to Employment Agreement, dated December 7, 2022 between CEVA Ireland Sweden Filial and Gweltaz Toquet</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.3*</div>
			</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_455179.htm" style="-sec-extract:exhibit;">Employment Agreement, dated May 11, 2021, between CEVA Ireland Sweden Filial and Gweltaz Toquet</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">99.1</div>
			</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_455180.htm" style="-sec-extract:exhibit;">Press release issued on December 12, 2022 by CEVA, Inc.</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: auto; text-align: center;">104</td>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">* Denotes management contract, compensatory plan or arrangement.</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;text-indent:9pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;text-indent:9pt;"><b><span style="text-decoration: underline;">Signature</span></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td colspan="2" style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>CEVA, INC.</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td colspan="2" style="vertical-align:bottom;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:28.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: December 12, 2022</div>
			</td>
			<td style="vertical-align:top;width:2.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">By:</div>
			</td>
			<td style="vertical-align: top; width: 25.5%; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>/s/ Yaniv Arieli</i></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Name:</div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Yaniv Arieli</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&#xa0;</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Title:</div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Financial Officer</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex_455177.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
	<title>ex_455177.htm</title>

	<!-- Generated by ThunderDome Portal - 12/10/2022 10:06:39 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="1" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="1" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: right;"><b>Exhibit 10.1</b></p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: small-caps; margin: 0pt; text-align: right;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Separation and Release Agreement</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">This Separation and Release Agreement (the &#8220;Agreement&#8221;), dated December 7, 2022, 2022, is made by and between Issachar Ohana<b> </b>(&#8220;you&#8221;) and CEVA Development, Inc. (the &#8220;Company&#8221;). This Agreement is effective on the 8<sup style="vertical-align:top;line-height:120%;">th</sup> day after you sign it, provided you do not revoke it before that day in accordance with Section 5(b) of this Agreement (the &#8220;Effective Date&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>1.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Separation Date. </b>Your last day of employment with the Company is December 31<sup style="vertical-align:top;line-height:120%;">st</sup>, 2022 (the &#8220;Separation Date&#8221;). Whether or not you sign this Agreement, on the Separation Date, the Company will provide you with your final paycheck, which will include your final wages and all accrued, unused vacation and floating holidays through your Separation Date, less applicable taxes and withholdings. In accordance with Section 4.4 of your Employment Agreement (as defined below), the Company will pay you an amount equal to thirty (30) days of your base salary in lieu of the notice required by your Employment Agreement (the &#8220;Notice Payment&#8221;). The Notice Payment will be made on the Company&#8217;s first regular payroll date after the Separation Date. After the Separation Date, you will not represent yourself as being an employee, officer, attorney, agent, or representative of the Company for any purpose.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>2.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Severance Package.</b> As contemplated in your Employment Agreement dated November 1, 2002 and any amendments thereto (the &#8220;Employment Agreement&#8221;), if you execute, do not revoke, and remain at all times in compliance with this Agreement, including without limitation, any confidentiality provisions in your prior agreements with the Company and those as defined below, the Company will provide you with the following severance package (collectively, the &#8220;Severance Benefits&#8221;):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;"><b>a.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;Severance Payment. </b>The Company shall pay you $614,564.00, which is an amount equal to two (2) years of your current annual base salary (the &#8220;Severance&#8221;). The Severance will be paid less applicable deductions and withholdings and paid to you in equal installments on the Company&#8217;s regular payroll dates over a period of two (2) years after the Separation Date (&#8220;the Severance Period&#8221;), with the first such payment paid on the Company&#8217;s first payroll date after the Separation Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;"><b>b.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;Health Insurance. </b> Your benefits under the Company&#8217;s group health plans will continue until the end of the month in which the Separation Date occurs. After that date, as provided by the Consolidated Omnibus Budget Reconciliation Act (&#8220;COBRA&#8221;) and by the Company&#8217;s current group health insurance policies, you will be eligible to continue your health insurance benefits in order to provide you and your spouse and covered dependents with the health benefits required by Section 5.2(b) of your Employment Agreement under COBRA to continue coverage for yourself and your spouse and covered dependents under the Company&#8217;s group health plans, the Company will pay COBRA directly an amount equal to the premiums the Company would have paid on your behalf for such coverage had you remained an active employee until the earliest of (1) the two (2) year anniversary of the Separation Date; (2) the date you become eligible for health insurance coverage from a new employer or through self-employment; or (3) the date you are no longer eligible to continue coverage under COBRA. .</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;"><b>c.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;2022 Bonus. </b>The Company will pay you an amount equal to any unpaid incentive compensation you would have been eligible to earn under the 2022 Incentive Bonus Plan (the &#8220;IB Plan&#8221;) for you achieving recognized revenue targets through December 31, 2022. Such amounts will be paid to you, less applicable deductions and withholdings, in accordance with the terms of the IB Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;"><b>d.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;401(k) Plan Make-Whole.</b> The Company will provide you with payments totaling of $36,874, less any applicable deductions, withholdings, or taxes, which is an amount equal to two (2) years of the largest employer 401(k) Plan contribution allowed if you were still employed by the Company, based on your base salary immediately prior to the date of this Agreement. Such payments will be paid in equal installments on the Company&#8217;s regular payroll dates over the duration of the Separation Period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;"><b>e.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;Equity. </b>Your current 11,196 unvested time-based restricted stock units (&#8220;RSUs&#8221;) granted under your RSU award agreements between the Company and you (the &#8220;RSU Award Agreements&#8221;) will immediately vest in full on the Effective Date and otherwise your rights and obligations to all such RSUs will continue to be governed by the RSU Award Agreements and the Company&#8217;s 2011 Stock Incentive Plan (the &#8220;Plan&#8221;). Your 4,769 performance-based stock units (&#8220;PSUs&#8221;) granted in February 2022 will vest if and to the extent the applicable performance goals are achieved, which achievement shall be determined by the Company&#8217;s Board of Directors (or a committee thereof) in the ordinary course based on actual performance through 2022, and, if and to the extent such performance goals are achieved, the number of PSUs that would have been eligible to vest had your employment not terminated will vest as of the date of the Board of Director&#8217;s (or committee&#8217;s) determination of achievement of the performance goals. With respect to your remaining 2,980 unvested PSUs granted under your PSU award agreements between the Company and you dated February 20, 2020 and Feb 18, 2021 shares will immediately vest on the Effective Date (reflecting acceleration of time-based vesting component for the current period). Except as modified by this Agreement, your rights and obligations with respect to all such vested PSUs will continue to be governed by the applicable PSU award agreements and the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;"><b>f.&nbsp;&nbsp;&nbsp; </b> <b>Cell Phone.</b>&nbsp;&nbsp;Immediately after the Separation Date, the Company will take all reasonable steps to transfer the cell phone numbers you were issued in Israel (***-***-****) and in the United States (***-***-****) to you for your personal use.&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>3.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Other Compensation or Benefits.</b> You acknowledge that, except as expressly provided in this Agreement, you are not entitled to and will not receive any additional compensation or benefits from the Company after the Separation Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>4.</b><b>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp; Expense Reimbursements.</b> Within thirty (30) days of the Separation Date, you agree to submit your final documented expense reimbursement statement reflecting any and all business expenses you incurred through the Separation Date for which you seek reimbursement according to the Company&#8217;s policy. The Company will reimburse you for such expenses pursuant to its regular business practice and policy.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;"><b>5.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; General Release and Waiver.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;"><b>a.</b>&nbsp;&nbsp;&nbsp;&nbsp; In exchange for the Severance Benefits and other consideration under this Agreement, to which you would not otherwise be entitled, and except as otherwise set forth in this Agreement, you, on behalf of yourself and, to the extent permitted by law, heirs, executors, administrators, assigns, insurers, attorneys and other persons or entities, acting or purporting to act on your behalf (collectively, the &#8220;Employee Parties&#8221;), hereby generally and completely release, acquit and forever discharge the Company, CEVA, Inc., its parents, subsidiaries, and investors, and its and their officers, directors, managers, partners, agents, representatives, employees, attorneys, shareholders, predecessors, successors, assigns, insurers and affiliates (the &#8220;Company Parties&#8221;) of and from any and all claims, liabilities, demands, contentions, actions, causes of action, suits, costs, expenses, attorneys&#8217; fees, damages, indemnities, debts, judgments, levies, executions and obligations of every kind and nature, in law, equity, or otherwise, both known and unknown, suspected and unsuspected, disclosed and undisclosed, arising out of or in any way related to agreements, events, acts or conduct at any time prior to and including the execution date of this Agreement, including but not limited to: all such claims and demands directly or indirectly arising out of or in any way connected with your employment with the Company or the termination of that employment; claims or demands related to salary, bonuses, commissions, stock, stock options, or any other ownership interests in the Company, vacation pay, fringe benefits, expense reimbursements including internet, mobile and travel, severance pay, or any other form of compensation; claims pursuant to your Employment Agreement (and any international assignment or amendment thereof); claims pursuant to any federal, state or local law, statute, or cause of action; tort law; or contract law (individually a &#8220;Claim&#8221; and collectively &#8220;Claims&#8221;). The Claims you are releasing and waiving in this Agreement include, but are not limited to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:63pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">all Claims for breach of contract, breach of quasi-contract, promissory estoppel, detrimental reliance, and breach of the implied covenant of good faith and fair dealing;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:63pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">all tort Claims, including Claims for fraud, defamation, slander, libel, negligent or intentional infliction of emotional distress, personal injury, negligence, compensatory or punitive damages, negligent or intentional misrepresentation, and discharge in violation of public policy;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:63pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">all federal, state, and local statutory Claims, including Claims for discrimination, harassment, retaliation, attorneys&#8217;&nbsp;fees, medical expenses, experts&#8217;&nbsp;fees, costs and disbursements; and</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:63pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">any other Claims of any kind whatsoever, from the beginning of time until the date you sign this Agreement, in each case whether based on contract, tort, statute, local ordinance, regulation or any comparable law in any jurisdiction.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">By way of example and not in limitation, Claims released include any Claims arising under Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; 42 U.S.C. &#167;&nbsp;1981, as amended; the Age Discrimination in Employment Act (&#8220;ADEA&#8221;); the Equal Pay Act; the Americans With Disabilities Act; the Genetic Information Nondiscrimination Act; the Family and Medical Leave Act; the Employee Retirement Income Security Act; the Employee Polygraph Protection Act; the Worker Adjustment and Retraining Notification Act; the anti-retaliation provisions of the Sarbanes-Oxley Act, or any other federal or state law regarding whistleblower retaliation; the Lilly Ledbetter Fair Pay Act; the Uniformed Services Employment and Reemployment Rights Act; the Fair Credit Reporting Act; the National Labor Relations Act; the&nbsp;California&nbsp;Fair Employment and Housing Act; the&nbsp;California&nbsp;Labor Code; the&nbsp;California&nbsp;Constitution; the&nbsp;California&nbsp;Family Rights Act; and/or any other federal, state, local or foreign law (statutory, regulatory, or otherwise) that may be legally waived and released. YOU UNDERSTAND AND AGREE THAT THIS AGREEMENT CONTAINS A GENERAL RELEASE OF ALL CLAIMS.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;"><b>b.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;Specific Release of ADEA Claims.</b> You further unconditionally release and forever discharge the Company Parties from any and all Claims that the Employee Parties may have as of the date you sign this Agreement arising under the ADEA. By signing this Agreement, you acknowledge and confirm that: (i) you have been advised by the Company to consult with an attorney of your choice before signing this Agreement; (ii) you were given no fewer than twenty-one (21) days to consider the terms of the Agreement, although you may sign it sooner if desired; (iii) you are signing this Agreement in exchange for good and valuable consideration which is in addition to anything of value to which you are already entitled; (iv) you have seven (7) days from the date of signing this Agreement to revoke this Agreement by delivering to the Company a written notice of revocation that is received by the Company before the end of such seven-day period to Yaniv Arieli, CFO, yaniv.arieli@ceva-dsp.com, but you understand that you will not be eligible for any Payment if you revoke this Agreement because your eligibility for any such Payment is contingent upon you signing and not revoking the Agreement; (v) the release contained in this Section does not apply to rights and claims that may arise after the date on which you sign this Agreement, and (vi) you knowingly and voluntarily accept the terms of this Agreement. You further agree that any change to this Agreement, whether material or immaterial, will not restart the twenty-one (21) day period for you to consider the terms of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;"><b>c.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;Protected Rights.</b> Notwithstanding the foregoing, other than events expressly contemplated by this Agreement you do not waive or release rights or Claims that may arise from events that occur after the date this waiver is executed. Also excluded from this Agreement are any Claims which cannot be waived by law, including, without limitation, any rights you may have under applicable workers&#8217; compensation laws. Nothing in this Agreement shall prevent you from filing, cooperating with, or participating in any proceeding or investigation before the Equal Employment Opportunity Commission, the Securities and Exchange Commission, or any other federal government agency, or similar state or local agency (&#8220;Government Agencies&#8221;). You further understand this Agreement does not limit your ability to voluntarily communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company. While this Agreement does not limit your right to receive an award for information provided to the Government Agencies, you understand and agree that, you are otherwise waiving, to the fullest extent permitted by law, any and all rights you may have to individual relief based on any Claims that you have released and any rights you have waived by signing this Agreement. If any Claim is not subject to release, to the extent permitted by law, you waive any right or ability to be a class or collective action representative or to otherwise participate in any putative or certified class, collective or multi-party action or proceeding based on such a Claim in which any of the Company Parties is a party. This Agreement does not abrogate your existing rights under any Company benefit plan, but it does waive, release and forever discharge Claims existing as of the date you execute this Agreement pursuant to any such plan or agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;"><b>d.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;Waiver of Section 1542.</b> You also agree that because this release specifically covers known and unknown claims, you waive your rights under Section 1542 of the California Civil Code or any other comparable statute of any jurisdiction, which states as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 72pt; text-indent: 0pt;"><b>&#8220;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY</b><b>.</b>&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;"><b>e.</b><b>&nbsp;&nbsp;&nbsp;&nbsp;Release by Company.</b> In consideration for this Agreement, each of the Company Parties hereby waives and releases all Claims known or unknown that any of them may have against you or your spouse, dependents, heirs, successors and assigns, provided, however, that the none of the Company Parties release any Claims that involve intentional, reckless, or grossly negligent conduct, including, but not limited to, actions involving fraud, embezzlement, breach of fiduciary duty, and misappropriation of trade secrets.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>6.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Your Acknowledgments and Affirmations</b>. You acknowledge and agree that you have been paid for all time worked, have received all the leave, leaves of absence and leave benefits and protections for which you are eligible, and have not suffered any on-the-job injury for which you have not already filed a Claim. You affirm that all of the decisions of the Company Parties regarding your pay, benefits, and other terms and conditions of employment through the date of your execution of this Agreement were not discriminatory based on age, disability, race, color, sex, religion, national origin or any other classification protected by law. You represent and warrant that you have not reported any alleged improper conduct or activity about the Company or the Company Parties to the Company or any of the Company Parties and you have no knowledge of any such conduct or activity. You further acknowledge that you have not been retaliated against for reporting any allegations of wrongdoing to the Company or the Company Parties. You affirm that you have not filed or caused to be filed, and are not presently a party to, a Claim against any of the Company Parties. You further affirm that you have no known workplace injuries or occupational diseases.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>7.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Return of Company Property.</b> By no later than 30 days from the Separation Date, you agree to return to the Company all documents (and all copies thereof), data, and other property of the Company, CEVA, Inc., or any of their parents or subsidiaries, that you have had in your possession at any time, including, but not limited to, Company files, notes, drawings, records, business plans and forecasts, financial information, specifications, computer-recorded information, tangible property (including, but not limited to, the Dell Laptop computers), entry cards, identification badges and keys; and, any materials of any kind that contain or embody any proprietary or confidential information of the Company (and all reproductions thereof), except that you may retain the Company iPad and the iPhone in your possession, provided that you erase all Company information and data from such devices. Any information or data you created on behalf of the Company, and CEVA, Inc., or any of their parents or subsidiaries, that is on your personal devices, accounts, and email that is not on the Company&#8217;s systems and, you agree to permanently delete and erase all such information from your personal devices, accounts, and emails. Please coordinate return of Company property with Yaniv Arieli, CFO, yaniv.arieli@ceva-dsp.com. .</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>8.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Confidential Information.</b> You acknowledge that in the course of your work for the Company, you were given, had access to and/or otherwise learned of Confidential Information (as defined below) of the Company and its respective clients, affiliates, customers, suppliers or other third parties, (2) such Confidential Information constitutes highly valuable assets of the Company; and (3) disclosure of such Confidential Information would cause undue harm to the Company and its respective clients, affiliates, customers, suppliers or other third parties. In acknowledgement of the foregoing, you agree that you have and will continue to hold all Confidential Information in strict confidence and you have and will not use, reproduce, disclose or deliver, directly or indirectly, any Confidential Information except to the extent necessary to perform your duties as an employee of the Company or as permitted by a duly authorized representative of the Company. You further agree that you will use your best efforts to prevent the unauthorized use, reproduction, disclosure or delivery of Confidential Information by others.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;"><b>a.</b>&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, &#8220;Confidential Information&#8221; means any and all non-public information and materials, in whatever form, tangible or intangible, whether disclosed to or learned or developed by you before or after the execution of this Agreement, whether or not marked or identified as confidential or proprietary, pertaining in any manner to the business of or used by the Company, CEVA, Inc., and its and their affiliates and subsidiaries, or pertaining in any manner to any person or entity to whom the Company owes a duty of confidentiality. Confidential Information includes, but is not limited to, the following types of information and materials: (i) research, development, technical or engineering information, know-how, data processing or computer software, programs, tools, data, designs, diagrams, drawings, schematics, sketches or other visual representations, plans, projects, manuals, documents, files, photographs, results, specifications, trade secrets, inventions, discoveries, compositions, ideas, concepts, structures, improvements, products, prototypes, instruments, machinery, equipment, processes, formulas, algorithms, methods, techniques, works in process, systems, technologies, disclosures, applications and other materials; (ii) financial information and materials, including, without limitation, information and materials relating to costs, vendors, suppliers, licensors, profits, markets, sales, distributors, joint venture partners, customers, subscribers, members and bids, whether existing or potential; (iii) business and marketing information and materials, including, without limitation, information and materials relating to future development and new product concepts; and (iv) any other information or materials relating to the past, present, planned or foreseeable business, products, developments, technology or activities of the Company. Confidential Information does not include any information or materials that you can prove by written evidence: (i)&nbsp;is or becomes publicly known through lawful means and without breach of this Agreement by you or breach by you of any other nondisclosure agreement with the Company; (ii)&nbsp;was rightfully in your possession or part of your general knowledge prior to your employment by the Company; or (iii)&nbsp;is disclosed to you without confidential or proprietary restrictions by a third party who rightfully possesses the information or materials without confidential or proprietary restrictions. However, to the extent the Company owes a duty of confidentiality to a third party with respect to such information, idea or material, such information, idea or material shall continue to be Confidential Information until such time as the Company&#8217;s duty of confidentiality terminates or expires.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;"><b>b.</b>&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary in this Agreement, nothing in this Agreement shall prohibit or interfere with you exercising protected rights under federal, state or local laws, including but not limited to rights under the National Labor Relations Act; filing a charge with the Equal Employment Opportunity Commission; reporting possible violations of law to or participating in an investigation by any federal, state or local government agency or commission such as the National Labor Relations Board, the Department of Labor, OSHA, the Department of Justice, or the Securities and Exchange Commission.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;"><b>c.</b>&nbsp;&nbsp;&nbsp;&nbsp;You acknowledge receipt of the following pursuant to 18 U.S.C. &#167; 1833(b)(1) (Defend Trade Secrets Act):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 36pt; text-align: justify; text-indent: 0pt;">An individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made in confidence to a federal, state, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law. An individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal; and does not disclose the trade secret, except pursuant to court order.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>9.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Confidentiality.</b> You agree that the provisions of this Agreement will be held in strictest confidence by you and will not be publicized or disclosed in any manner whatsoever; <i>provided, however</i>, that: (a) you may disclose this Agreement to your immediate family; (b) you may disclose this Agreement in confidence to your attorney, accountant, auditor, tax preparer, and financial advisor; and (c) you may disclose this Agreement insofar as such disclosure may be required by law. Nothing in this Section or this Agreement restricts or impedes you from exercising protected rights, including rights under the National Labor Relations Act or the federal securities laws, to the extent that such rights cannot be waived by agreement or from complying with any applicable law or regulation or a valid order of a court of competent jurisdiction or an authorized government agency, provided that such compliance does not exceed that required by the law, regulation, or order.<b> </b>Nothing in this Agreement shall be deemed to prevent the discussion or disclosure of information related to unlawful acts in the workplace, including harassment, discrimination or related retaliation, including any conduct you have reasonable cause to believe is unlawful.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>10.</b><b>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp; Mutual Non-Disparagement</b>. Subject to the protections in Section 5(c) and 8, and 9, you agree and covenant that you shall not at any time make, publish, or communicate to any person or entity or in any public forum any defamatory, maliciously false, or disparaging remarks, comments, or statements concerning the Company, CEVA, Inc., or its subsidiaries, or any of their employees, officers, or directors, existing and prospective customers, suppliers, and investors. The Company, its current officers and directors shall not at any time make, publish, or communicate to any person or entity or in any public forum any defamatory, maliciously false, or disparaging remarks, comments, or statements concerning you; provided that this restriction only applies to such officers while they are employed by the Company. Nothing in this Agreement prohibits you, the Company, or its officers and directors from initiating, testifying, assisting, complying with a subpoena from, or participating in any manner with an investigation conducted by the appropriate local, state, or federal agency.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>11.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Cooperation.</b> The parties agree that certain matters in which you have been involved during your employment may need your cooperation with the Company in the future. Accordingly, for the two (2) year period after the&nbsp;Separation&nbsp;Date, to the extent requested by the Company, you shall cooperate with the Company regarding matters arising out of or related to the your service to the Company, including, without limitation, assisting the Company with any litigation or government investigations in which the Company is involved and to which you may have relevant knowledge; provided that the Company shall make reasonable efforts to minimize disruption of your other activities and reimburse you for reasonable and necessary expenses. In the event such cooperation requires a substantial commitment of your time, the parties will discuss, in good faith, if any remuneration is necessary to compensate for your time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>12.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;No Admission. </b>This Agreement does not constitute an admission by the Company of any wrongful action or violation of any federal, state, or local statute, or common law rights, including those relating to the provisions of any law or statute concerning employment actions, or of any other possible or claimed violation of law or rights.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>13.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Breach of Agreement. </b>In the event of a breach or threatened breach by you of Sections 8, 9, 10, or 11 of this Agreement or the terms and conditions of any prior confidentiality agreement between you and the Company, you acknowledge and agree that money damages would not afford an adequate remedy and that the Company shall be entitled to seek a temporary or permanent injunction or other equitable relief against such breach or threatened breach from any court of competent jurisdiction, without the necessity of showing any actual damages, and without the necessity of posting any bond or other security. Any equitable relief shall be in addition to, not instead of, legal remedies, monetary damages, or other available relief. In addition, in the&nbsp;event that you breach any your obligations in Sections 8, 9, 10, or 11 of this Agreement or the terms and conditions of any prior confidentiality agreement between you and the Company, and you fail to cure such breach (if curable) within twenty (20) calendar days after the Company has served you with written notice specifying the breach, demanding a cure, the Company may, in additional to other available remedies, reclaim any amounts paid to you under the provisions of Section 2 of this&nbsp;Agreement, without waiving the releases or other rights provided in this Agreement. In the event of any legal action to enforce or interpret this Agreement, the prevailing party in such action shall be awarded reasonable attorneys&#8217; fees and costs.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>14.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; Acknowledgment of Full Understanding</b>. <b>YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE FULLY READ, UNDERSTAND, AND VOLUNTARILY ENTER INTO THIS</b>&nbsp;<b>AGREEMENT. YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE HAD AN OPPORTUNITY TO ASK QUESTIONS AND CONSULT WITH AN ATTORNEY OF YOUR CHOICE BEFORE SIGNING THIS</b>&nbsp;<b>AGREEMENT. </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>15.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Section 409A</b>. It is intended that this Agreement comply with Section 409A of the Internal Revenue Code of 1986, as amended, and related Treasury regulations (&#8220;Section 409A&#8221;) or an exemption therefrom, and this Agreement will be interpreted accordingly; provided, however, the Company makes no representation that any or all of the payments described in this Agreement will be exempt from or comply with Section 409A and makes no undertaking to preclude Section 409A from applying to any such payment. You understand and agree that you are solely responsible for the payment of any taxes, penalties, interest or other expenses you incur on account of noncompliance with Section 409A.&nbsp; Payments pursuant to 2(a) are intended to constitute a series of separate payments for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii).&nbsp; Any reimbursements provided pursuant to this Agreement that constitute deferred compensation for purposes of Section 409A shall be provided in a manner that complies with Treasury Regulation Section 1.409A-3(i)(1)(iv).&nbsp; Accordingly, (a) all such reimbursements will be made not later than the last day of the calendar year after the calendar year in which the expenses were incurred, (b) any right to such reimbursements will not be subject to liquidation or exchange for another benefit, and (c) the amount of the expenses eligible for reimbursement during any taxable year will not affect the amount of expenses eligible for reimbursement in any other taxable year.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><b>16.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; Miscellaneous.</b> This Agreement, including any confidentiality provisions agreed to by the Company and you, constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with regard to this subject matter. It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations. This Agreement may not be modified or amended except in a writing signed by both you and a duly authorized officer of the Company. This Agreement will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns. If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question will be severed or modified by the court so as to not affect the validity of the remainder of the Agreement, which shall remain in full force and effect and continue to be binding on the parties. Captions and headings of the sections and paragraphs of this&nbsp;Agreement&nbsp;are intended solely for convenience and no provision of this&nbsp;Agreement&nbsp;is to be construed by reference to the caption or heading of any section or paragraph. Moreover, this&nbsp;Agreement&nbsp;shall not be construed against either party as the author or drafter of the&nbsp;Agreement. This Agreement will be deemed to have been entered into and will be construed and enforced in accordance with the laws of the State of California, without regard to conflict of laws principles. Any action or proceeding by either of the parties to enforce this Agreement shall be brought only in a state or federal court located in Santa Clara County, California. The parties hereby irrevocably submit to the exclusive jurisdiction of such courts and waive the defense of inconvenient forum to the maintenance of any action or proceeding in such venue.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td colspan="2" style="width: 5%;" valign="top" width="38%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font><b>CEVA Development, Inc.</b></p>
			</td>
			<td style="width: 65%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 5%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" style="width: 30%;" valign="bottom" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 65%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="text-align: left; width: 5%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By: </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="width: 30%; border-bottom: 1px solid rgb(0, 0, 0);" valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/&nbsp;</font>Gideon Wertheizer</p>
			</td>
			<td style="width: 65%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 5%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Name:</p>
			</td>
			<td style="width: 30%;" valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font>Gideon Wertheizer</p>
			</td>
			<td style="width: 65%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 5%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Title:</p>
			</td>
			<td style="width: 30%;" valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font>CEO</p>
			</td>
			<td style="width: 65%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 5%;" valign="top" width="3%">&nbsp;</td>
			<td style="width: 30%;" valign="top" width="35%">&nbsp;</td>
			<td style="width: 65%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 5%; border-bottom: 1px solid rgb(0, 0, 0);" valign="top" width="3%">&nbsp;</td>
			<td style="width: 30%; border-bottom: 1px solid rgb(0, 0, 0);" valign="top" width="35%">December 7, 2022&nbsp;&nbsp;</td>
			<td style="width: 65%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 5%;" valign="top" width="3%">Date</td>
			<td style="width: 30%;" valign="top" width="35%">&nbsp;</td>
			<td style="width: 65%;" valign="top" width="12%">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td colspan="2" style="width: 5%;" valign="top" width="38%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><b>Issachar Ohana</b></p>
			</td>
			<td style="width: 65%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 5%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" style="width: 30%;" valign="bottom" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 65%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td colspan="2" rowspan="1" style="text-align: left; width: 5%; border-bottom: 1px solid rgb(0, 0, 0);" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/&nbsp;</font>Issachar Ohana</p>
			</td>
			<td style="width: 65%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td colspan="2" rowspan="1" style="width: 5%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Signature</p>
			</td>
			<td style="width: 65%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 5%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 30%;" valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 65%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 5%; border-bottom: 1px solid rgb(0, 0, 0);" valign="top" width="3%">&nbsp;</td>
			<td style="width: 30%; border-bottom: 1px solid rgb(0, 0, 0);" valign="top" width="35%">December 7, 2022</td>
			<td style="width: 65%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 5%;" valign="top" width="3%">Date</td>
			<td style="width: 30%;" valign="top" width="35%">&nbsp;</td>
			<td style="width: 65%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 5%;" valign="top" width="3%">&nbsp;</td>
			<td style="width: 30%;" valign="top" width="35%">&nbsp;</td>
			<td style="width: 65%;" valign="top" width="12%">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="10" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">10</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex_455178.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html><head>
	<title>ex_455178.htm</title>

	<!-- Generated by ThunderDome Portal - 12/10/2022 10:10:15 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 10.2</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font><img alt="cevalogo01.jpg" src="cevalogo01.jpg"></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ADDENDUM TO EMPLOYMENT AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">This addendum to the employment agreement (this &#8220;<b>Addendum</b>&#8221;) is entered into on this day between:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">CEVA Ireland Sweden Filial, reg. no. 516407-9062, Klarabergsviadukten 70, Box 70396, Stockholm (&#8220;<b>CEVA Europe</b>&#8221;); and</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Gweltaz Toquet, personal ID no.&nbsp;*********** , ***********, Sweden.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">CEVA Europe and Gweltaz Toquet are hereinafter jointly referred to as the &#8220;<b>Parties</b>&#8221;. CEVA Europe&#8217;s parent company, CEVA Inc. (&#8220;<b>Parent</b>&#8221;), together with CEVA Europe and Parent&#8217;s other direct and indirect subsidiaries, are collectively referred to as &#8220;<b>CEVA</b>&#8221; or the &#8220;<b>Company Group.</b>&#8221;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>1</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>BACKGROUND </b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Gweltaz Toquet has been employed by CEVA Europe as CEVA&#8217;s VP Sales APAC since 1 June 2021. Gweltaz Toquet is as of 1 January 2023 offered a new role as CEVA&#8217;s Chief Commercial Officer (&#8220;<b>CCO</b>&#8221;). The Parties have therefore agreed upon the following in addition to and variation of the Employment Agreement entered into on 11 May 2021 (the &#8220;<b>Employment Agreement</b>&#8221;).</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>2</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>THE EMPLOYMENT </b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Gweltaz Toquet is as of 1 January 2023 (&#8220;<b>Promotion Date</b>&#8221;) employed as CEVA&#8217;s CCO (Chief Commercial Officer). Gweltaz Toquet shall dedicate all his working hours to CEVA and may not have other employment which disrupts his work, competes with CEVA in a manner which can cause harm to, or in any other manner damage, CEVA&#8217;s business. If Gweltaz Toquet is contemplating taking up other employment, he must first consult with CEVA. Generally, Gweltaz Toquet is not entitled to agree to have professional engagements or other outside professional activities without written permission from the board of directors.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In light of the job responsibilities and employment terms and conditions, Gweltaz Toquet may be deemed to have a managerial or comparable position and only the relevant sections of the Employment Protection Act of Sweden shall apply.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>3</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>WORKPLACE</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Until further notice, Gweltaz Toquet&#8217;s workplace shall continue to be combining home office and CEVA Europe&#8217;s premises at the above address.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In light of the job responsibilities and employment terms and conditions, Gweltaz Toquet is obliged to travel worldwide and perform work at CEVA&#8217;s other locations, and in particular he needs to be in the U.S. up to every 6<sup style="vertical-align:top;line-height:120%;">th</sup> week on average in accordance with instructions given by CEVA&#8217;s CEO from time to time.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>4</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>REMUNERATION </b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Gweltaz Toquet&#8217;s salary is SEK 2,320,000 per annum and shall ordinarily be paid in 12 monthly arrears on the 25th of each month to a designated bank account.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">CEVA Europe shall pay employer contributions on the amount and withhold customary preliminary income tax in accordance with applicable provisions.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The salary also includes remuneration for board of directors work and other work which Gweltaz Toquet performs on behalf of CEVA.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>5</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>COMMISSION AND RESTRICTED STOCK UNITS </b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Gweltaz Toquet shall be entitled to participate in CEVA&#8217;s commission plan applicable from time to time. Gweltaz Toquet commission plan will be SEK 1,750,000 per annum.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Gweltaz Toquet shall be entitled to participate in CEVA&#8217;s Officers&#8217; Equity Plan applicable from time to time.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Parent&#8217;s compensation committee shall approve, effective on the Promotion Date, a grant of Restricted Stock Units (&#8220;RSU&#8221;) under an equity incentive plan of Parent with value equal to $100,000, with the exact number of RSUs to be equal to such value divided by the closing price of Parent&#8217;s common stock as quoted on Nasdaq on the close of trading on the Promotion Date. One-third of such RSUs will vest on each anniversary of the Promotion Date, subject to Gweltaz Toquet&#8217; continued service with CEVA.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Per Parent&#8217;s board of directors&#8217; decision, Gweltaz Toquet will be regarded as a Section 16 officer for U.S. SEC reporting obligations.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The right to any payment is conditional upon Gweltaz Toquet still being employed by CEVA Europe or another member of the Company Group at the time of the disbursement.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>6</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>TERMINATION OF THE EMPLOYMENT</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">A mutual notice period of six (6) months shall apply.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">During the notice period, Gweltaz Toquet shall be at CEVA&#8217;s disposal to perform any and all job responsibilities he previously performed or could be required to perform in the capacity as CCO.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Notwithstanding which party gives notice of termination, CEVA Europe shall be entitled to relieve Gweltaz Toquet from his duties during all or part of the notice period.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">This Agreement will come to an end once Gweltaz Toquet reaches the age of Retirement as per existing Law. Notwithstanding the foregoing, the Addendum and Employment Agreement may be extended for another year subject to a prior written notice by both parties to this Addendum.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>7</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>DISMISSAL OR TERMINATION WITHOUT NOTICE</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">If Gweltaz Toquet gives notice of termination or terminates this Agreement with immediate effect for Good Reason, Gweltaz Toquet shall remain entitled to notice pay. &#8220;<b>Good Reason</b>&#8221; shall mean the death of Gweltaz Toquet or the occurrence, without his written consent, of any of the events or circumstances set forth in clauses (a) through (d) below. Notwithstanding the occurrence of any such event or circumstance, such occurrence shall not be deemed to constitute Good Reason if such event or circumstance has been fully corrected and Gweltaz Toquet has been reasonably compensated for any losses or damages resulting therefrom (provided that such right of correction by the CEVA shall only apply to the first notice of termination for Good Reason given by Gweltaz Toquet) within 15 days following written notice from Gweltaz Toquet to CEVA notifying CEVA of such event.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(a)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The assignment to Gweltaz Toquet of duties inconsistent in any material respect with Gweltaz Toquet&#8217;s position (including status, offices, titles and reporting requirements), authority or responsibilities, or any other action or omission by CEVA Europe or the Parent which results in a material diminution in such position, authority or responsibilities.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(b)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">A reduction in Gweltaz Toquet&#8217;s annual base salary as set forth in Section 4 or as may be increased from time to time in accordance with Section 4, except for a comparable reduction in salary affecting all similarly situated employees.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(c)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The failure by CEVA to (i) continue in effect any material compensation or benefit plan or program (including without limitation any life insurance and any vacation policy, but excluding any medical or health plan or other benefits that are in fact or may instead be provided for or sponsored by applicable government agencies) in which Gweltaz Toquet participates or which is applicable to Gweltaz Toquet pursuant to the Employment Agreement (a &#8220;<b>Benefit Plan</b>&#8221;), unless an equitable arrangement (embodied in an ongoing substitute or alternative plan) has been made with respect to such Benefit Plan, or (ii) continue the Gweltaz Toquet&#8217;s participation therein (or in such substitute or alternative Benefit Plan), on a basis not materially less favourable, both in terms of the amount of benefits provided and the level of the Employee&#8217;s participation relative to other participants, than the basis existing on the date hereof or as may be agreed from time to time by the CEVA and Gweltaz Toquet.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(d)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Any material breach by CEVA Europe of this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Notwithstanding anything to the contrary herein, CEVA Europe may terminate Gweltaz Toquet&#8217;s employment for Cause without advance notice ,without paying notice pay and without derogating from any remedy to which CEVA Europe may be entitled. A termination for "<b>Cause</b>" is termination due to:</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(i)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Gweltaz Toquet&#8217;s willful engagement in illegal conduct or gross misconduct which is materially and demonstrably injurious to CEVA or any member of the Company Group, including, without limitation, embezzlement of funds of CEVA or the Company Group.</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; vertical-align: top;">
			<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">(ii)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; margin: 0pt; text-align: justify;">(ii) Gweltaz Toquet&#8217;s material breach of (x) the terms and conditions of this Addendum and Employment Agreement and any exhibits or annexes hereto, (y) Parent&#8217;s Code of Conduct and Business Ethics, posted on Parent&#8217;s website and updated from time to time, as well as any other material policies applicable to similarly situated Company Group employees, or (z) any other material employment-related agreement between Gweltaz Toquet and CEVA or any member of the Company Group, in each case where Gweltaz Toquet has failed to remedy such failure or refusal within 15 days following written notice from CEVA to Gweltaz Toquet notifying him thereof (unless CEVA determines in its reasonable discretion that such breach is of a kind that cannot be cured within such 15 day period);</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; vertical-align: top;">
			<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">(iii)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">a good-faith finding by Parent&#8217;s Chief Executive Officer (&#8220;<b>CEO</b>&#8221;) or board of directors that Gweltaz Toquet&#8217;s (x) has failed to perform his reasonably assigned duties or has refused to use good-faith efforts to comply with the directives of Parent&#8217;s CEO or board of directors and (y) has failed to remedy such failure or refusal within 15 days following written notice from CEVA to Gweltaz Toquet notifying him thereof.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">(iv)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Gweltaz Toquet&#8217;s involvement in any other act or engagement in any other conduct which, as determined by Parent&#8217;s CEO or board of directors, constitutes a breach of trust between himself and CEVA or any member of the Company Group or could cause grave injury to CEVA or any member of the Company Group, monetarily or otherwise;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">(v)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Gweltaz Toquet is indicted of, or pleads guilty or nolo contendere (or any analogous pleading) to, any crime involving moral turpitude or any felony;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">(vi)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Gweltaz Toquet is adjudicated bankrupt or makes any arrangement or composition with Gweltaz Toquet&#8217;s creditors; or</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; vertical-align: top;">
			<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">(vii)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Gweltaz Toquet becomes of unsound mind or is committed as patient for the purposes of any legislation relating to mental health.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other than the cases set forth above, CEVA Europe also may terminate Gweltaz Toquet&#8217;s employment without the Notice Period (or part thereof) if it pays Gweltaz Toquet that sum equal to the Salary that he would otherwise be entitled to during the denied Notice Period</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>8</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>ADDITIONAL TERMS REGARDING TERMINATION AND NON-DISCLOSURE BETWEEN THE PARTIES ARE ATTACHED HERETO AS APPENDIX A AND APPENDIX B TO THIS ADDENDUM, RESPECTIVELY. </b>The promotion and remuneration terms set forth in this Addendum are contingent on on Gweltaz Toquet&#8217;s agreement to the terms of Appendix B as of the Promotion Date.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>9</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>MISCELLANEOUS</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In all other aspects not covered by this Addendum, the employment terms and conditions laid down in the Employment Agreement shall apply.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">This Addendum may be changed, supplemented or modified only by a written instrument duly executed by or on behalf of each party hereto.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">This Addendum shall be governed by and construed in accordance with the laws of Sweden.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 131pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">This Addendum has been executed in one (1) or multiple copies and signed digitally. Each such signed copy shall be deemed an original and all of which together shall constitute one and the same Addendum, of which each Party shall receive a PDF copy.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><u>Israel 12/7/22</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><br>
			Place and date</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><u>Stockholm, 12/7/2022</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><br>
			Place and date</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">CEVA Ireland Sweden Filial</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><u>/s/ Gideon Wertheizer</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><br>
			Gideon Wertheizer, CEO</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><u>/s/ Gweltaz Toquet</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><br>
			Gweltaz Toquet</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>APPENDIX A</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>Additional Terms Relating to Termination </u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">This Appendix is entered into as of the 1st day of January, 2023, between CEVA Ireland Sweden Filial, reg. no. 516407-9062, Klarabergsviadukten 70, Box 70396, Stockholm, (the "<b>Company</b>") and Gweltaz Toquet I.D. No. ********** (the &#8220;<b>Employee</b>&#8221;) and is intended to establish additional terms relating to the termination of employment relations between the parties, as established in the employment agreement dated December 7, 2022 (the "<b>Agreement</b>").&nbsp; Capitalized terms used and not defined herein shall have the meanings set forth in the Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Notwithstanding any provision to the contrary in the Agreement, in the event that Employee&#8217;s employment relationship is terminated by the Employee for Good Reason (as defined in the Agreement) or by the Company, or any acquiring or succeeding corporation of the Company or CEVA, Inc. (the "<b>Parent</b>"), without Cause (as defined in the Agreement) within 12 months after a Change in Control (as defined below), the Company shall:</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(i)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">pay to the Employee an amount equal to the compensation to which the Employee would otherwise have been entitled had the Employee remained employed by the Company for one-year after such termination (based on the Employee&#8217;s salary as in effect on the date of termination), which may be paid in a lump sum or in the form of salary continuation at the Company&#8217;s discretion; and</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(ii)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">the time-based vesting of any equity awards granted to the Employee by the Parent shall accelerate in full.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">2.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The payment to the Employee of the amounts payable hereunder shall (i) be contingent upon the execution by the Employee of a release in a form reasonably acceptable to the Company, and (ii) constitute the sole remedy of the Employee in the event of a termination of the Employee&#8217;s employment in the circumstances set forth herein.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">3.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">For purposes of this Appendix, &#8220;<b>Change in Control</b>&#8221;&nbsp;shall mean the consummation of a merger, consolidation or reorganization involving the Parent, a transaction involving the sale or exchange of greater than 50% of the voting stock of the Parent or a sale or other disposition of all or substantially all of the assets of the Parent in one or a series of transactions (a &#8220;<b>Business Combination</b>&#8221;), unless, immediately following such Business Combination, all or substantially all of the individuals and entities who were the beneficial owners of the Common Stock of the Parent immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the combined voting power of the then-outstanding securities entitled to vote generally in the election of directors of the resulting or acquiring corporation in such Business Combination in substantially the same proportions as their ownership of the Common Stock of the Parent immediately prior to such Business Combination.</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">IN WITNESS WHEREOF, the parties hereby execute this Employment Agreement.</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 15%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Signature:</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Employee&#8217;s name:</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Identity number:</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Date:</p>
			</td>
			<td style="width: 85%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><u>/s/ Gweltaz Toquet</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp; &nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><u>Gweltaz Toquet</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><u>7301261579</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp; &nbsp; &nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><u>12/7/2022</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CEVA Ireland Sweden Filial By: Gideon Wertheizer <u>/s/ Gideon Wertheizer</u> Title: CEO</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>Annex B </b>&#8211;<b> NDA</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NON-DISCLOSURE, NON-SOLICIT AND ASSIGNMENT OF IDEAS AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 14pt;text-indent:36pt;">This Non-Disclosure, Non-Compete and Assignment of Ideas Agreement (the &#8220;Agreement&#8221;) is made as of December 7, 2022 (the &#8220;Effective Date) by and between Gweltaz Toquet (&#8220;Employee&#8221;) and <b>CEVA Ireland Sweden Filial. </b>(the &#8220;Employer&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 12pt;text-indent:37pt;">WHEREAS, Employer is engaged in a competitive market and owns and continues to develop valuable Confidential Information (as defined below);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 12pt;text-indent:37pt;">WHEREAS, as a condition of employment or continued employment with Employer, Employee is required to enter into this Agreement to protect Employer&#8217;s Confidential Information and intellectual property; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 10pt;text-indent:37pt;">WHEREAS, Employee desires to be employed by Employer and understands that such employment will expose Employee to existing or future Confidential Information of Employer, and further understands that the services to be provided are of a unique nature for the Employer, and that Employee&#8217;s breach of the restrictions and covenants in this Agreement will result in irreparable harm to the Employer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 16pt;text-indent:36pt;">NOW, THEREFORE, in consideration of Employee&#8217;s employment, access to the Employer&#8217;s Confidential Information, and of the mutual covenants contained herein, Employer and Employee, intending to be legally bound, agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Confidential Information</u>. &#8220;Confidential Information&#8221; means non-public information and materials related in any manner to Employer&#8217;s and CEVA, Inc.&#8217;s and their parents, subsidiaries, and affiliates (collectively, the &#8220;Company Group&#8217;s&#8221;) business or pertaining in any manner to any person or entity to whom any entity in the Company Group owes a duty of confidentiality, including but not limited to, patent files and patent applications, business plans, marketing plans, customer and prospective customer information, vendor and prospective vendor information, prices, costs, financial matters, internal business methods and strategy, employment matters, production and engineering activities, product design, inventions, trade secrets, ideas, concepts, know-how, methods, techniques, engineering concepts, product specifications, software, algorithms, computer programs, compilation of information, written descriptions, drawings, copyrighted materials, samples, demonstrations, manufacturing processes, research and development efforts, names and addresses and capabilities employees and consultants, and any other data or information relating to the business and operations of the Company Group, which is not generally known by or not readily accessible to the public. Employee understands and acknowledges that in the course of Employee&#8217;s employment with Employer, Employer may incur substantial expenditures of time and money in providing Employee with specialized instruction and training, and that Employee will have access and/or be exposed to certain of the Company Group&#8217;s Confidential Information. Notwithstanding the foregoing, Confidential Information does not include any information or materials that Employee can prove by written evidence: (i)&nbsp;is or becomes publicly known through lawful means and without breach of this Agreement by Employee; (ii)&nbsp;was rightfully in Employee&#8217;s possession or part of Employee&#8217;s general knowledge prior to Employee&#8217;s employment by the Employer; or (iii)&nbsp;is disclosed to Employee without confidential or proprietary restrictions by a third party who rightfully possesses the information or materials without confidential or proprietary restrictions. However, to the extent any entity in the Company Group owes a duty of confidentiality to a third party with respect to such information, idea or material, such information, idea or material shall continue to be Confidential Information until such time as such duty of confidentiality terminates or expires. If Employee is uncertain as to whether particular information or materials are Confidential Information, Employee will request the Employer&#8217;s written opinion as to their status.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Non-disclosure</u>. The parties agree that it is of great importance to the success of Employer and the Company Group that Confidential Information be treated with great care and that improper disclosure and improper use be prevented.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 16pt;text-indent:73pt;">a.&nbsp;&nbsp;&nbsp;&nbsp;Employee agrees to abide by all Employer&#8217;s rules and procedures designed to protect Confidential Information. Employee agrees that, during Employee&#8217;s employment with Employer and at all times thereafter, Employee will hold the Confidential Information in strict confidence. Employee further agrees to use the Confidential Information solely for the purposes of providing services to Employer and agrees to maintain as secret and shall not, directly or indirectly, disclose, use, or publish or permit the disclosure, use, or publication of, any Confidential Information to a third party, unless such disclosure, use, or publication is consented to in advance in a writing executed by a duly authorized representative of Employer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 15pt;text-indent:76pt;">b.&nbsp;&nbsp;&nbsp;&nbsp;Nothing in this Agreement prohibits Employee from reporting possible violations of federal law or regulation to any government agency or entity, including, but not limited to the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, or from making other disclosures that are protected under the whistleblower provisions of federal or state law or regulation or from the terms and conditions of Employee&#8217;s employment with others to the extent permitted by Section 7 of the National Labor Relations Act. Employee acknowledges that Employee does not need the prior authorization of Employer to make any such reports or disclosures and is not required to notify Employer of any such reports or disclosures. Furthermore, in accordance with the Defend Trade Secrets Act of 2016, Employee will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney and (b) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 15pt;text-indent:76pt;">c.&nbsp;&nbsp;&nbsp;&nbsp;Employee understands and acknowledges that Employee&#8217;s obligations under this Agreement with regard to any Confidential Information shall commence immediately upon Employee first having access to such Confidential Information (whether before or after Employee began employment with the Employer) and shall continue during and after Employee&#8217;s employment with the Employer until such time as such Confidential Information has become public knowledge other than as a result of Employee&#8217;s breach of this Agreement or breach by those acting in concert with Employee or on Employee&#8217;s behalf. Notwithstanding the foregoing, it is understood that, at all such times, Employee is free to use information which was known to Employee prior to employment with the Employer or which is generally known in the trade or industry through no breach of this Agreement or other act or omission by Employee. If a temporal limitation on Employee&#8217;s obligation not to use or disclose such information is required under applicable law, and the Agreement or its restriction(s) cannot otherwise be enforced, Employee agrees and the Employer agrees that the two (2) year period after the date Employee&#8217;s employment ends will be the temporal limitation relevant to the contested restriction, provided, however, that this sentence will not apply to trade secrets protected without temporal limitation under applicable law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 13pt;text-indent:38pt;">3.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<u>Privacy; Protection of Personal Information</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 15pt;text-indent:76pt;">a.&nbsp;&nbsp;&nbsp;&nbsp;<u>Privacy</u>. Employee acknowledges that the Employer may access all information and materials generated, received or maintained by or for Employee on the premises or equipment of the Employer (including, without limitation, computer systems and electronic or voice mail systems), and Employee hereby waives any privacy rights Employee may have with respect to such information and materials.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 15pt;text-indent:76pt;">b.&nbsp;&nbsp;&nbsp;&nbsp;<u>Protection of Personal Information</u>. During Employee&#8217;s employment with the Employer and thereafter, Employee shall hold Personal Information in the strictest confidence and shall not disclose or use Personal Information about other individuals, except in connection with Employee&#8217;s work for the Employer, or unless expressly authorized in writing by an authorized representative of the Employer. Employee understands that there are laws in the United States and other countries that protect Personal Information, and that Employee must not use Personal Information about other individuals other than for the purposes for which it was originally used or make any disclosures of other individuals&#8217; Personal Information to any third party or from one country to another without prior approval of an authorized representative of the Employer. Employee understands that nothing in this Agreement prevents Employee from discussing Employee&#8217;s wages or other terms and conditions of Employee&#8217;s employment with co-workers or others, unless such discussion would be for the purpose of engaging in unfair competition or other unlawful conduct.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 15pt;text-indent:76pt;">c.&nbsp;&nbsp;&nbsp;&nbsp;<u>Definition of Personal Information</u>. &#8220;<b>Personal Information</b>&#8221; means personally identifiable information about employees, independent contractors or third-party individuals, including names, addresses, telephone or facsimile numbers, Social Security Numbers, background information, credit card or banking information, health information, or other information entrusted to the any entity in the Company Group.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 13pt;text-indent:38pt;">4.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<u>Ownership and Assignment</u>. Employee shall promptly disclose to Employer any and all Intellectual Property (as defined below), whether or not patentable or copyrightable, made, developed, discovered, conceived, or reduced to practice by Employee, solely or jointly, during the period of Employee&#8217;s employment with Employer, whether or not conceived or made during working hours, and relating in any manner to the business of Employer and whether or not at the request or suggestion of Employer. For the purposes of this Agreement, &#8220;Intellectual Property&#8221; includes but is not limited to trade secrets, inventions, mask works, ideas, concepts, diagrams, specifications, methods, processes, formulas, algorithms, source and object codes, data, programs, other works of authorship, derivative works, know-how, improvements, modifications, discoveries, developments, designs and techniques in any stage of development, whether or not patentable or reduced to practice and whether or not copyrightable. Employee hereby assigns and agrees to assign automatically upon creation to Employer all worldwide right, title and interest in and to all Intellectual Property that are made, conceived, discovered, developed or reduced to practice by Employee (either alone or jointly with others), or result from or are suggested by any work performed by Employee (either alone or jointly with others) for or on behalf of the Employer or any entity in the Company Group, (i) during the period of Employee&#8217;s employment with the Employer, whether before or after the execution of this Agreement and whether or not made, conceived, discovered or developed during regular business hours or (ii) during or after the period of Employee&#8217;s employment with the Employer, whether before or after the execution of this Agreement, if based on or using Confidential Information or otherwise in connection with Employee&#8217;s activities as an employee of the Employer (collectively, the &#8220;Employer Inventions&#8221;). Employee agrees and acknowledges that all such Employer Inventions shall be the exclusive property of Employer with respect to all countries and all rights therein shall vest and inure to the benefit of the Employer. Employee understands and acknowledges that all copyrightable Employer Inventions shall be deemed a work for hire for purposes of the United States Copyright laws, and Employer shall have the sole right, title and interest in such work. Employee understands and acknowledges that Employer may license, assign, sell, or otherwise transfer at will the Employer Inventions without compensation to Employee. Employee recognizes that this Agreement will not be deemed to require assignment of any Intellectual Property that is developed entirely on Employee&#8217;s own time without using the Employer&#8217;s or the Company Group&#8217;s equipment, supplies, facilities, Confidential Information, which is not related to the Employer&#8217;s or the Company Group&#8217;s actual or anticipated business, research or development, and which does not result from work performed by Employee for any entity in the Company Group. In addition, this Agreement does not apply to any Intellectual Property which qualifies fully for protection from assignment to Employer under any specifically applicable state law, regulation, rule or public policy. If, under applicable law notwithstanding the foregoing, Employee retains any right, title or interest (including any intellectual property right) with respect to any Employer Invention, Employee hereby grants and agrees to grant to the Employer, without any limitations or additional remuneration, an exclusive, royalty-free, irrevocable, perpetual, transferable, worldwide license (with rights to sublicense through multiple tiers of sublicensees) to reproduce, distribute, display, perform (whether publicly or otherwise), prepare derivative works of and otherwise modify, make, have made, sell, offer to sell, practice any method in connection with, import and otherwise use and exploit such Employer Invention and Employee agree not to make any claim against Employer or any entity in the Company Group, suppliers or customers with respect to such Employer Invention.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 13pt;text-indent:38pt;">5.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<u>Prior Inventions; Employee Inventions</u>. Intellectual Property, if any, patented or unpatented, which Employee made prior to the commencement of Employee&#8217;s employment with the Employer are excluded from the scope of this Agreement. To preclude any possible uncertainty, Employee has set forth on <u>Appendix</u><u>&nbsp;</u><u>A</u><i> </i>(Prior Inventions) attached hereto a complete list of all Intellectual Property that Employee has, alone or jointly with others, conceived, developed or reduced to practice or caused to be conceived, developed or reduced to practice prior to the commencement of Employee&#8217;s employment with the Employer, that Employee considers to be Employee&#8217;s property or the property of third parties and that Employee wishes to have excluded from the scope of this Agreement (collectively referred to as &#8220;<u>Prior Inventions</u>&#8221;). A space is provided on <u>Appendix</u><u>&nbsp;</u><u>A</u> for such purpose. If no such disclosure is attached, Employee represents that there are no Prior Inventions. Employee shall not, without prior written approval by Employer incorporate into any property of Employer or any entity in the Company Group or Employer Inventions any Intellectual Property owned by Employee or in which Employee has an interest (&#8220;Employee Invention&#8221;) or owned by a third party. If, in the course of Employee&#8217;s employment with the Employer, Employee incorporates an Employee Invention into any property of Employer or any entity in the Company Group or Employer Invention (with or without the Employer&#8217;s approval), Employee hereby grants and agrees to grant to the Employer, without any limitations or additional remuneration, a nonexclusive, royalty-free, irrevocable, perpetual, transferable, worldwide license (with rights to sublicense through multiple tiers of sublicensees) to reproduce, distribute, display, perform (whether publicly or otherwise), prepare derivative works of and otherwise modify, make, have made, sell, offer to sell, practice any method in connection with, import and otherwise use and exploit such Prior Invention.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 13pt;text-indent:38pt;">6.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<u>Cooperation</u>. At the request of Employer, Employee (both during Employee&#8217;s employment and thereafter) shall perform all lawful acts and execute, acknowledge and deliver all such instruments deemed necessary or desirable by Employer to vest or maintain in Employer or in any designee of Employer all right, title and interest in anything recited in Sections 4 and 5 hereof, and cooperate with Employer to prepare, file and prosecute applications for patents, trademarks, copyrights and similar registrations thereof in all countries selected by Employer, including renewals and reissues thereof and to obtain and record sole and exclusive title to such applications, patents, trademarks, copyrights and similar registrations for all said countries. In the event the Employer is unable for any reason, after reasonable effort, to secure Employee&#8217;s signature on any document needed in connection with the actions specified in the preceding sections, Employee hereby irrevocably designates and appoints the Employer and its duly authorized officers and agents as Employee&#8217;s agent and attorney in fact, which appointment is coupled with an interest, to act for and in Employee&#8217;s behalf to execute, verify and file any such documents and to do all other lawfully permitted acts to further the purposes of the preceding sections with the same legal force and effect as if executed, verified or filed by Employee. Employee hereby waives and quitclaims to the Employer all of Employee&#8217;s individual rights under patent, copyright or other intellectual property legislation arising in connection with all Employer Inventions and any and all claims, of any nature whatsoever, which Employee now or may hereafter have for infringement of any rights assigned to the Employer under this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 12pt;text-indent:37pt;">7.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<u>Duty of Loyalty during Employment.</u> Employee understands that Employee&#8217;s employment by the Employer requires Employee&#8217;s full attention and effort, and Employee agrees to devote Employee&#8217;s full attention and effort to performing the duties of Employee&#8217;s position with the Employer. Employee agrees that during the period of Employee&#8217;s employment by the Employer Employee will not, without the Employer&#8217;s express written consent, engage in any employment or business activity other than for the Employer, which is competitive with, or would otherwise conflict with or distract Employee from, Employee&#8217;s employment by the Employer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 12pt;text-indent:37pt;">8.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<u>Non-Solicitation of Employees and Consultants</u>. During Employee&#8217;s employment with Employer and during the one (1) year period after Employee&#8217;s employment terminates for any reason, , including voluntary or involuntary terminations (the &#8220;Restriction Period&#8221;), Employee agrees that Employee shall not, directly or indirectly, solicit or induce, or attempt to solicit or induce any employee or independent contractor of Employer or any entity in the Company Group to: (i) cease employment with Employer or any entity in the Company Group, or (ii) work for any other person or entity that competes with the Employer or any entity in the Company Group; provided that the restrictions in this Section only apply to employees and independent contractors of the Employer and members of the Company Group whom Employee had contact with or learned Confidential Information about during Employee&#8217;s last twelve (12) months of employment with the Employer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 12pt;text-indent:37pt;">9.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<u>Non-Solicitation of Customers</u>. During the Restriction Period, Employee agrees not to, directly or indirectly: (a)&nbsp;solicit any Customers (as defined below) of the Employer for purposes that are competitive to the Employer, (b)&nbsp;request or cause any Customers of the Employer to curtail, cancel, materially diminish or terminate their business with the Employer or elect not to do business with the Employer, or (c)&nbsp;use the Employer&#8217;s Confidential Information to solicit any Customers (except where such solicitation is on the behalf of Employer) or otherwise interfere with any business relationship or contract between the Employer and any Customer. For purposes of this Agreement, a &#8220;Customer&#8221; means any person or entity that during the last twelve (12) months of Employee&#8217;s employment with the Employer: (i)&nbsp;contracted for, was billed for, or received from the Employer any product, service or process where Employee had direct or indirect contact with or acquired Confidential Information about such person or entity; (ii)&nbsp;was in contact with Employee concerning the sale or purchase of, or contract for, any product, service or process with the Employer; or (iii)&nbsp;was solicited by Employee on behalf of the Employer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 12pt;text-indent:36pt;">10.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<u>Non-Competition</u>. During the Restriction Period, Employee agrees not to (except with the prior written consent of an authorized representative of the Employer), directly or indirectly, perform or attempt to perform anywhere in a Restricted Territory (as defined below) any Restricted Services (as defined below) that are competitive to the Employer. For the purposes of this Agreement, &#8220;Restricted Territory&#8221; means the twenty-five (25) mile radius around any of the following locations: (i)&nbsp;any Employer business location at which Employee has worked on a regular or occasional basis during Employee&#8217;s employment; (ii)&nbsp;Employee&#8217;s home if Employee worked from home on a regular or occasional basis; (iii)&nbsp;any potential business location of the Employer under active consideration by the Employer to which Employee has travelled in connection with the consideration of that location; or (iv)&nbsp;any county, parish, or similar political subdivision in the United States where Employee provided services on behalf of the Employer or had a material presence during the last twelve (12) months prior to Employee&#8217;s termination of employment with the Employer. For purposes of this Agreement, &#8220;Restricted Services&#8221; are any services that are the same or substantially similar to the services Employee performed for Employer in the last two (2) years of Employee&#8217;s employment with the Employer. In the event the employment terminates following notice of termination for any reason other than retirement, during such time as the Non-Competition clause is in force, the Employer shall be obligated to pay to the Employee, on a monthly basis, the difference between (x) their monthly income from employment by the Employer at the time of termination of the employment (the &#8220;Termination base Salary&#8221;) and (y) the (lower) income (the &#8220;Non-Competition Compensation&#8221;) which they actually receive, or could have received, from other employment, another engagement, or in other business activities for work performed during the term of applicability of the Non-Competition clause without violation of the Non-Competition clause (such difference, the &#8220;Non-Competition Make-Whole Payment&#8221;). However, the Non-Competition Make-Whole Payment shall not exceed 60% of the previous deemed monthly base salary at the time of termination of the employment, where such deemed monthly base salary shall be calculated as the average fixed wages paid to the Employee during the most recently completed 12 calendar months of employment (or such lesser number of months as may apply if the Employee has served for less than a year). For the avoidance of doubt, consideration shall be taken only of such time during which the Employee performed work in the customary position pursuant to the applicable employment agreement. The Employer shall have no obligation to pay a Non-Competition Make-Whole Payment where it is proven that the Non-Competition Compensation is lower than the Termination Salary not as a consequence of the non-Competition clause. To the extent reasonable, the Employee shall limit the loss in income which may occur as a consequence of the application of the non-Competition clause. The Employee shall be obligated to provide, on a monthly basis, the information, inter alia regarding the amount of their income from new employment or business activities, as required by the Employer in order to determine the Non-Competition Make-Whole Payment. In the event the employment terminates for Cause (as defined in the Addendum to Employment Agreement between Employee and Employer dated of even date herewith), the Employer shall not be obligated to pay any Non-Competition Make-Whole Payment. In the event the Employee receives a separate compensation from the Employer due to the termination of the employment, e.g. as a result of change in control or for any reason, the compensation shall be considered to fully compensate the Employee for the Non-Competition clause in lieu of the Non-Competition Make-Whole Payment as long as the compensation fully compensates the Employee during the Restrictive Period with in total 60% of the Termination Salary. The Employer may unilaterally limit or revoke the Non-Competition clause up until the latter to occur of (i) the termination of Employee&#8217;s employment or (ii) in the event of voluntary termination by the Employee, two weeks after the notice in writing to the Employer of such termination (such latter date, the &#8220;Outside Date&#8221;). In any event, not later than within two weeks of the Outside Date, the Employer shall inform the Employee whether, and to what extent, the non-Competition clause shall apply with regard to its scope and term of applicability. The Employer may not unilaterally modify this information.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 12pt;text-indent:37pt;">11.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<u>Reasonableness of Restrictions</u>. Employee agrees that this Agreement does not prevent Employee from earning a living or pursuing Employee&#8217;s career. Employee acknowledges and understands that the nature of Employee&#8217;s position with the Employer gives Employee access to and knowledge of Confidential Information and the Employer will in fact give Employee access to Confidential Information, such that it places Employee in a position of trust and confidence with the Employer. Employee further agrees and acknowledges that the services Employee will provide to the Employer are unique, special, or extraordinary. Employee also acknowledges that the ability to reserve these for the exclusive knowledge and use of the Employer is of great competitive importance and commercial value to the Employer and that improper use or disclosure by Employee is likely to result in unfair or unlawful competitive activity. In addition, Employee acknowledges and agrees that Employee has and will receive mutually agreeable consideration to support enforcement of the restrictions in this Agreement, including but not limited to, his salary, benefits, and other compensation and consideration. Accordingly, Employee acknowledges and agrees that the Employer has a legitimate interest in protecting its business, such that the foregoing restrictions are reasonable, proper and necessary in light of the Employer&#8217;s interests and the consideration received by Employee. Employee represents and agrees that Employee is entering into this Agreement freely and with knowledge of its contents with the intent to be bound by the Agreement and the restrictions contained in it.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 12pt;text-indent:37pt;">12.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<u>Obligations on Termination</u>. On termination of employment with Employer for any reason, Employee agrees to deliver to Employer any and all tangible embodiments (regardless of form) of Confidential Information and all property of Employer and any entity in the Company Group and equipment, and tangible embodiments of materials relating to anything within the terms of Sections l and 4 of this Agreement. Employee shall retain no copies, excerpts or portions of any item delivered pursuant to this Section. In addition, upon termination of Employee&#8217;s employment with Employer for any reason, Employee will deliver to a member of Employer&#8217;s Human Resources Department, all property (e.g., keys, access badges, etc.) and any and all documents, records, files, computer programs and/or other data relating to any Confidential Information and to the Employer&#8217;s business or operations. Employee further agrees to permanently delete any such records residing on any computer or computer program in Employee&#8217;s possession upon termination of Employee&#8217;s employment. In addition, if Employee has used any personal computer, server, or e-mail system to receive, store, review, prepare or transmit any information of Employer or any entity in the Company Group, including but not limited to, Confidential Information, Employee agrees to provide Employer with a computer-useable copy of all such Confidential Information and then permanently delete and expunge such Confidential Information from those systems; and Employee agrees to provide the Employer access to Employee&#8217;s system as reasonably requested to verify that the necessary copying and/or deletion is completed. Employee further agrees that any property situated on the Employer&#8217;s premises and owned by the Employer, including electronic, magnetic and other storage devices and media, filing cabinets or other work areas, is subject to inspection by Employer personnel at any time with or without notice.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 12pt;text-indent:37pt;">13.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<u>Assignability</u>. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors, legal representatives and permitted assigns. Notwithstanding the foregoing, Employer shall have the right to assign in whole or in part (whether by operation of law or otherwise), this Agreement or any of its rights or obligations under this Agreement at Employer&#8217;s sole discretion. Employee may not assign this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 12pt;text-indent:37pt;">14.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<u>Reformation/Severability</u>. Employee expressly agrees that the provisions of this Agreement are reasonably required by Employer to protect the legitimate business interests of Employer and the Company Group. The Employee and Employer agree that if a court of competent jurisdiction should determine that any of the foregoing provisions are unenforceable, in whole or in part, then such court is authorized to modify such agreement or covenant in such respects as such court determines to be required in order that it shall, as so modified, be enforceable to the fullest extent permitted by applicable law. If any provision of this Agreement is declared void or unenforceable by any judicial or administrative authority, the remaining provisions of this Agreement will not be nullified but will remain in full force and effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 12pt;text-indent:37pt;">15.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<u>Remedies</u>. Employee expressly acknowledges and agrees that (i)&nbsp;the provisions of this Agreement are reasonable and necessary for the protection of Employer and the Company Group, (ii)&nbsp;Employee&#8217;s obligations herein are of a unique and special nature, (iii)&nbsp;any breach or violation of Employee&#8217;s obligations herein will result in irreparable harm to Employer and the Company Group for which there may be no adequate remedy at law, (iv)&nbsp;in addition to all other remedies, Employer shall be entitled as a matter of right to injunctive relief in any court of competent jurisdiction, together with an equitable accounting of all earnings, profits or other benefits arising from a violation of any provision of this Agreement, which rights shall be cumulative, (v)&nbsp;Employee shall not assert as a defense to any petition or request for injunctive or other equitable relief the claim that Employer has an adequate remedy at law, and (vi)&nbsp;Employer shall not be required to post a bond or other security in connection with a request for injunctive or other equitable relief. Employee agrees that if the Employer is successful in whole or in part in any legal or equitable action against Employee under this Agreement, the Employer will be entitled to payment of all costs, including reasonable attorneys&#8217; fees, from Employee. In the event the Employer enforces this Agreement through a court order, Employee agrees that the restrictions of Sections 8, 9, and 10 of this Agreement will remain in effect for a period of twelve (12) months from the effective date of the order enforcing the Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 12pt;text-indent:37pt;">16.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<u>No Waiver</u>. The failure of either Employer or Employee to object to any conduct or violation of any of the agreements or obligations made by the other under this Agreement will not be deemed a waiver of any rights or remedies. No waiver of any right or remedy arising under this Agreement will be valid unless set forth in an appropriate writing signed by the party to be charged.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 12pt;text-indent:37pt;">17.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<u>Notification of New Employer</u>. In the event that Employee leaves the employ of the Employer, for a period of one (1) year following the termination of Employee&#8217;s employment by the Employer, upon Employer&#8217;s written request, Employee will notify the Employer of the identity of any subsequent employer within five (5) days of receiving such written request. Employee authorizes the Employer to provide notice of Employee&#8217;s rights and obligations under this Agreement to Employee&#8217;s subsequent employers and to any other entity or person to which Employee provides services or in which Employee has a financial interest. If Employee is offered employment or the opportunity to enter into any business venture as owner, partner, consultant or other capacity while the restrictions described in Sections 8, 9, and 10 of this Agreement are in effect, Employee agrees to inform Employee&#8217;s potential employer, partner, co-owner and/or others involved in managing the business with which Employee have an opportunity to be associated of Employee&#8217;s obligations under this Agreement and also agrees to provide such person or persons with a copy of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 12pt;text-indent:37pt;">18.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<u>No Employment Contract</u>. Employee and Employer expressly acknowledge and agree that the purpose of this Agreement is to protect the legitimate business interests of Employer and that this Agreement shall not be construed or enforced as an employment contract or give Employee any right or guarantee to be employed for any specific time or to limit Employer&#8217;s right to terminate Employee&#8217;s employment at that time, with or without cause. Employee understands that Employee&#8217;s employment with the Employer is at-will.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 12pt;text-indent:37pt;">19.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<u>Entire Agreement/Amendments</u>. This Agreement, which includes all of the exhibits hereto, replaces and supersedes all prior agreements between the Employer and Employee relating to the subject matter in this Agreement; <i>provided</i>, <i>however</i>, that this Agreement will not supersede any obligations the Employee may have with respect to confidentiality, non-competition, non-solicitation, non-interference or non-disparagement, or any similar obligations, under any other agreement with the Employer or an of its predecessors. No alteration, modification, amendment or other change to this Agreement shall be binding unless in writing and executed by both Employer and Employee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 12pt;text-indent:37pt;">20.<b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; GOVERNING LAW AND VENUE. </b>THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF SWEDEN, WITHOUT REFERENCE TO CONFLICT OF LAWS PRINCIPLES. THE PARTIES IRREVOCABLY CONSENT AND AGREE THAT ANY AND ALL ACTIONS AND PROCEEDINGS INITIATED BY OR ON BEHALF OF THE PARTIES AND ARISING DIRECTLY OR INDIRECTLY FROM THIS AGREEMENT SHALL BE BROUGHT AND LITIGATED IN THE STATE COURTS OF SWEDEN</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 12pt;text-indent:37pt;">21.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<u>Employee</u><u>&#8217;</u><u>s Acknowledgment</u>. Employee expressly acknowledges that Employee has been given the opportunity prior to entering into this Agreement to consult with Employee&#8217;s own counsel regarding Employee&#8217;s rights and obligations with respect to this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 19pt;text-indent:37pt;">IN WITNESS WHERE OF, the parties hereto have executed this Agreement as of the day and year first above written.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;text-indent:20pt;"><b>CEVA Ireland Sweden Filial.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 19pt;text-indent:37pt;"><u>/s/ Gideon Wertheizer</u>____________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 19pt;text-indent:37pt;">By: Gideon Wertheizer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 19pt;text-indent:37pt;">Title: CEO</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 19pt;text-indent:37pt;">Date</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 19pt;text-indent:37pt;"><b>EMPLOYEE</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 19pt;text-indent:37pt;"><u>/s/ Gweltaz Toquet</u>_______________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 19pt;text-indent:37pt;">Printed Name: Gweltaz Toquet&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 19pt;text-indent:37pt;">Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12/7/2022</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>APPENDIX A</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PRIOR INVENTIONS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 29pt;text-indent:-29pt;"><b>TO:</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>CEVA Ireland Sweden Filial</b><b><strike>.</strike></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>FROM:</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Gweltaz Toquet</u></b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>DATE:</b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<b><u>12/7/2022</u></b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 58pt;text-indent:-58pt;"><b>SUBJECT:</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Prior Inventions </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>1.</b>&nbsp; &nbsp; &nbsp; &nbsp;Except as listed in Section&nbsp;2 below, the following is a complete list of all inventions or improvements relevant to the subject matter of Employee&#8217;s employment by CEVA Ireland Sweden Filial. (the &#8220;<u>Employer</u>&#8221;) that have been made or conceived or first reduced to practice by Employee alone or jointly with others prior to Employee&#8217;s engagement by the Employer:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#9745;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No inventions or improvements.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See below:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 90%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 10%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 90%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 10%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 90%; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 10%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 90%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 10%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 90%; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 29pt;text-indent:-29pt;">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional sheets attached.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.</b>&nbsp; &nbsp; &nbsp; &nbsp;Due to a prior confidentiality agreement, Employee cannot complete the disclosure under Section&nbsp;1 above with respect to inventions or improvements generally listed below, the proprietary rights and duty of confidentiality with respect to which Employee owe to the following party or parties:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 29%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><b>Invention or Improvement&nbsp;</b></p>

			<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><b>Relationship</b></p>
			</td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 27%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; vertical-align: top;"><b>Party/Parties</b></td>
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 29%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 27%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;"><b>1.</b></td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 27%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 27%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;"><b>2.</b></td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 27%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 27%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;"><b>3.</b></td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 27%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 29%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#9744;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp; &nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex_455179.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<html><head>
	<title>ex_455179.htm</title>

	<!-- Generated by ThunderDome Portal - 12/10/2022 10:04:13 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: right;"><b>Exhibit 10.3</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><img alt="ex_455178img001.jpg" src="ex_455178img001.jpg"></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">10th May 2021</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Gweltaz Toquet, ******, </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Sweden</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Dear<b> Gweltaz,</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">On behalf of CEVA Ireland Sweden Filial having a principal place of business at: Klarabergsviadukten 70, Box 70396, Stockholm we are delighted to offer you the position of <b>VP Sales APAC </b>on the following conditions basis below:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Section 1: Position Details</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 18%; text-align: justify;">Job title:</td>
			<td style="width: 82%; text-align: justify;"><b>VP Sales APAC</b></td>
		</tr>
		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%; text-align: justify;">Location:</td>
			<td style="width: 82%; text-align: justify;">You will be based in the CEVA office in Stockholm, Sweden. You will be required to travel at least once a quarter to visit your APAC territories. As well as travel within Europe and to and from Israel and the USA as necessary for business needs.</td>
		</tr>
		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%; text-align: justify;">Department &amp; Manager:</td>
			<td style="width: 82%;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">You will be leading the sales team of APAC and will report to EVP WW Sales.</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">The employment relationship is based on mutual loyalty and trust. You shall carry out your duties in a proper, loyal and efficient manner and shall use your best endeavours to promote the interests and reputation of the CEVA and not do anything that is or may be harmful to it.</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">This Agreement shall enter into force as from June 1<sup style="vertical-align:top;line-height:120%;">st</sup> 2021</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%; text-align: justify;">Working Hours:</td>
			<td style="width: 82%;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">The employment is full-time. Your hours of work will be 9.00 am until 5.30 pm, with a 30-minute break for lunch.</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">&nbsp;</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">You will appreciate that it is in the nature of our business that additional hours may be required to be worked from time to time.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%; text-align: justify;">
			<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Employee&#8217;s Duties and&nbsp;</p>

			<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Representations</p>
			</td>
			<td style="width: 82%;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">The Employee represents warrants and undertakes all of the&nbsp;following:</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">&nbsp;</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">There are no other undertakings or agreements preventing, restricting or limiting Employee from committing him/herself in accordance with this Agreement and performing Employee's obligations hereunder.</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">&nbsp;</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">The employee will perform his position with professionalism, dedication, diligence, fidelity, and integrity. You will dedicate the best of your abilities, knowledge, experience, and all your energies and time for the benefit and advancement of the Company, at the highest and most efficient level.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%; text-align: justify;">Employee is not currently and shall not by entering into this Agreement and performing Employee's obligations hereunder be deemed to be (i) violating any right of Employee's former employer(s), or (ii) in breach of or in conflict with, any of Employee's obligations towards Employee's former employer(s), or under any agreement to which Employee is a party or by any obligation to which Employee is bound.</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Section 2: Remuneration</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 18%; text-align: justify;">Salary:</td>
			<td style="width: 82%; text-align: justify;">Your salary will be <b>SEK 1,500,000</b> per annum</td>
		</tr>
		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%; text-align: justify;">Sales Incentive:</td>
			<td style="width: 82%; text-align: justify;">Your Annual Target Incentive Bonus of <b>SEK 1,500,000</b> will be measured quarterly and paid quarterly. Additionally, this annual target will be prorated to your date of hire in Sweden at the first year from the 1<sup style="vertical-align:top;line-height:120%;">st</sup> June until 31<sup style="vertical-align:top;line-height:120%;">st</sup> December 2021.</td>
		</tr>
		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 18%; text-align: justify;">Total On-Target Cash</td>
			<td style="width: 82%; text-align: justify;"><b>SEK 3,000,000</b></td>
		</tr>
		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 18%; text-align: justify;">When paid:</td>
			<td style="width: 82%; text-align: justify;">You will be paid on the 25<sup style="vertical-align:top;line-height:120%;">th</sup> of each month in monthly instalments directly into your bank account.</td>
		</tr>
		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 18%; text-align: justify;">Bank details:</td>
			<td style="width: 82%; text-align: justify;">Upon your arrival, please provide the HR department with a copy of your bank account details.</td>
		</tr>
		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%; text-align: justify;">Tax details:</td>
			<td style="width: 82%; text-align: justify;">You undertake to apply for a tax relief at the Taxation of Research Workers Board (<i>Sw: Forskarskatten</i>&#228;<i>mnden</i>) within three months from the commencement date of this Agreement, and to inform the Company about any final tax relief decisions.</td>
		</tr>
		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 18%; text-align: justify;">Overtime remuneration:</td>
			<td style="width: 82%; text-align: justify;">You will not be entitled to separate overtime remuneration since this has been taken into consideration when establishing salary and other benefits.</td>
		</tr>
		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%; text-align: justify;">Cost and Expenditures:</td>
			<td style="width: 82%; text-align: justify;">The Company shall reimburse you for reasonable work-related costs and expenditures pursuant to the Company&#8217;s policy applicable from time to time. Costs and expenditures shall be verified with a receipt or the equivalent.</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Section 3: Benefits</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 18%; text-align: justify;">Health Cover:</td>
			<td style="width: 82%; text-align: justify;">You and your family will be coved for health cover under the CEVA Ireland Sweden Filial policy.</td>
		</tr>
		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%; text-align: justify;">Pension:</td>
			<td style="width: 82%;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">CEVA will contribute 10% of your gross salary to a pension scheme.</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">&nbsp;</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">Premium waiver insurance and long-term disability insurance shall be procured additional to the pension contributions. However, at no time may the pension costs exceed the amount which is fully deductible for the Company.</p>
			</td>
		</tr>
		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%; text-align: justify;">ESPP:</td>
			<td style="width: 82%; text-align: justify;">You may participate in the Employee Stock Purchase Plan (ESPP). This plan offers the purchase of CEVA shares at a discounted price. Specific information regarding this plan is to be provided under separate cover.</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 144pt;text-indent:-144pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 18%; text-align: justify;">Insurances:</td>
			<td style="width: 82%;">The Company shall purchase an occupational group life insurance (&#8220;TGL&#8221;) and a labour market non-fault liability insurance for occupational injuries (&#8220;TFA&#8221;) on your behalf.</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Section 4: Leave</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 18%; vertical-align: top; text-align: justify;">Annual leave:</td>
			<td style="width: 82%;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">You will be granted 25 days annual leave per vacation year. The vacation year runs from 1 April through 31 March of the following year. The qualifying year is the corresponding period during the immediately preceding vacation year.</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">&nbsp;</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">When calculating vacation pay, vacation supplement, vacation pay in lieu and so forth, the provisions of the Annual Leave Act and the Company&#8217;s policy shall apply.</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">The normal Swedish bank holidays comes in addition.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 144pt;text-indent:-144pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Section 5: Notice Period</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 18%; text-align: justify;">Notice Period:</td>
			<td style="width: 82%; text-align: justify;">A mutual notice period of three (3) months will be required by both sides to terminate this contract. When you have reached the age as referred to in Section 32a of the Employment Protection Act, the notice period shall be one month.</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 144pt;text-indent:-144pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Section 6: Confidentiality</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 18%; vertical-align: top; text-align: justify;"><b>Confidentiality:</b></td>
			<td style="width: 82%; text-align: justify;">You shall not, either before or after the termination of this contract, divulge any information relating to CEVA or associated Companies and shall retain in strictest confidence all information concerning the Group&#8217;s suppliers, customers, and agents and all technical and commercial information concerning the Group to which you may become party to as a permanent employee of CEVA. Consequently, you shall observe confidentiality regarding, for example, business methods, business relationships, marketing, employment terms and conditions, customer contacts, and so forth.</td>
		</tr>
		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%; text-align: justify;"><b>Exclusivity:</b></td>
			<td style="width: 82%; text-align: justify;">During your employment, you must devote your time, attention and skills exclusively to the business of CEVA and you must use your best endeavours to promote the interests, business and welfare of the Company.&nbsp; You will not, during the continuance of your employment engage in work or employment for any other party without the prior written consent of CEVA.</td>
		</tr>
		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%; text-align: justify;"><b>Unfair Competition:</b></td>
			<td style="width: 82%;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">You undertake, for a period of six (6) months, calculated as from the termination of the employment, to refrain from personally or through another person encouraging or persuading any person to terminate his/her employment at, or services for, the Company or a group company, in order to work in a competing business.</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">&nbsp;</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">The prohibition on recruitment shall apply to persons who, at the time of termination of your employment, were employed by, or consultants of, the Company or a group company and that you have worked together with during your employment with the Company or persons whose professional competences are of significant importance for the Company and the group of companies.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 144pt;text-indent:-144pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 18%; vertical-align: top;"><b>Customer protection:</b></td>
			<td style="width: 82%;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">Upon termination your employment, you shall not be entitled to bring the Company&#8217;s customers to a company which competes with the Company. You undertake instead to endeavour to have these customers remain with, or return to, the Company. Your undertaking shall remain in force for a period of twelve (12) months from the termination of the employment.</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">&nbsp;</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">&#8220;The Company&#8217;s customers&#8221; means such customers as the Company had at the time of termination of the employment or has had for one (2) year prior thereto. &#8220;Customers&#8221; also means potential customers who, at the time of termination of the employment or for one (2) year prior thereto, were in negotiations with the Company.</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">&nbsp;</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">A customer is primarily regarded as the legal entity or natural person with whom the Company has, has had, or intended to enter into, a direct business relationship. A customer may also include companies closely related to customer companies (corporate group), natural persons who own or are part-owners of customer companies, and other companies which, directly or indirectly, are owned or operated by such a natural person.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 144pt;text-indent:-144pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 144pt;text-indent:-144pt;"><b>Section 7: Health &amp; Safety</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 144pt;text-indent:-144pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 18%; text-align: justify;">Health &amp; Safety:</td>
			<td style="width: 82%; text-align: justify;">You are required to comply with CEVA&#8217;s policy and rules relating to health and safety at work, as may be notified to you from time to time.</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 144pt;text-indent:-144pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Section 8: IT Issues etc.</b></p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">You undertake to respect the Company&#8217;s policy and procedures applicable from time to time in respect of the use of the</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Company&#8217;s IT equipment and systems. You confirm that you have read and understood the Privacy Notice for employees and the Company&#8217;s policy regarding processing of personal data and use of IT equipment and systems.</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">You are aware that the Company has access to all material and e-mail correspondence and monitors the use of the Internet which takes place in the Company&#8217;s IT systems.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 144pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Section 9: Penalty and Damages</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">Where you intentionally, or through gross negligence, breaches any of the provisions above regarding confidentiality, customer protection, prohibition on recruitment, you shall be obliged to pay to the Company, on each occasion, penalty equivalent to 6 times your average monthly income from the Company. &#8220;Average monthly income&#8221; means the average of the remuneration which you receive as fixed salary as well as variable salary elements such as commissions, bonuses, etc. during the most recent 12 months of employment.</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">&nbsp;</p>

			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">The foregoing penalty shall not prevent the Company from seeking full remuneration for financial loss incurred as a result of breach of any of the items in the preceding paragraph. In such case, the penalty amount so established shall be deducted from the amount of damages.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Section 10: Applicable law</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Swedish law shall be applied in respect of the origin, interpretation and application of this Agreement.</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">With respect to other employment terms and conditions which are not governed by this Agreement, applicable terms and conditions, policies, and so forth set forth in the Company&#8217;s personnel handbook shall apply.</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">This Agreement and its appendices constitute the complete governance of all issues pertaining to the employment. Any oral or written undertakings and promises which preceded the employment are superseded by this Agreement.</p>
			</td>
		</tr>
		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 18%;">&nbsp;</td>
			<td style="width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 18%; text-align: justify;">
			<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Changes to employment</p>

			<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">terms:</p>
			</td>
			<td style="width: 82%; text-align: justify; vertical-align: top;">Amendments of, and supplements to, this Agreement must be in writing and signed by both parties.</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As a condition of your employment, you are required to act in accordance with the policies and procedures set forth by CEVA Inc.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If the foregoing is acceptable to you, I would appreciate your signing a copy of this letter along with the &#8220;Intellectual Property Agreement&#8221; where indicated to signify your acceptance and return to myself.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We look forward to having you on-board and contributing to the rapid growth of CEVA Inc. now and in the future.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Yours sincerely,</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dana Maor</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">VP People</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">I have read, understood and confirm that I accept employment with CEVA Inc subject to the above terms and conditions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Signed:&nbsp;<u>/s/ Gweltaz Toquet</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date:&nbsp; &nbsp; <u>11 May 2021</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Start Date: June 1<sup style="vertical-align:top;line-height:120%;">st</sup>, 2021&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ex_455180.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_455180.htm</title>

	<!-- Generated by ThunderDome Portal - 12/10/2022 1:34:52 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="1" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="1" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><b>Exhibit 99.1</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div><img alt="a01.jpg" src="a01.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CEVA, Inc. Names Gweltaz Toquet as Chief Commercial Officer</b><br>
<br>
<i>Promoting company veteran after previously leading sales in APAC, India and Europe regions</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Rockville, MD, December 12, 2022</b><b><i> </i></b>&#8211;<i> </i>CEVA, Inc. (NASDAQ: CEVA), the leading licensor of wireless connectivity and smart sensing technologies and co-creation solutions, today announced that Gweltaz Toquet has been promoted to the role of Chief Commercial Officer (CCO) of CEVA, reporting directly to incoming CEO, Amir Panush, effective January 1, 2023. Mr. Toquet will assume responsibility for CEVA&#8217;s sales and customer success efforts worldwide, following Issachar Ohana&#8217;s departure from his position as Executive Vice President of Worldwide Sales effective December 31, 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Gideon Wertheizer, CEO of CEVA commented: &#8220;Gweltaz has played a pivotal role in CEVA&#8217;s successful expansion in the APAC during his 20 plus year career at CEVA. He has the right skillset and insight into our business and customers to lead our sales organization into our next phase of growth. I would also like to thank Issachar for his invaluable contribution to CEVA&#8217;s success over the past 20 years and wish him all the best in his future endeavors.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Mr. Toquet has more than 20 years of sales and management experience at CEVA, most recently serving as Vice President of Sales for APAC, India and Europe. Previously, he spent over 15 years in Hong Kong as CEVA&#8217;s Vice President of Sales for Asia, leading the build-out and management of the sales and support organization in the region, spanning China, Japan, Taiwan and Korea. Before joining CEVA in 2002, Mr. Toquet held several roles in sales, business development, product marketing and business line management at Freehand DSP and Texas Instruments. Mr. Toquet holds a MSE from the Institut Sup&#233;rieur d&#8217;Electronique de Paris (ISEP).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Gweltaz Toquet, incoming CCO of CEVA, stated: &#8220;I am honored to be appointed Chief Commercial Officer of CEVA. Our comprehensive portfolio of wireless connectivity and smart sensing technologies, and deep expertise in those domains, are extremely relevant and valuable in the quest for faster innovation and higher system integration in the end-markets we serve. I look forward to leading and scaling our sales organization to enable our customers&#8217; continuous success and CEVA&#8217;s growth trajectory.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Forward Looking Statements</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">This press release contains forward-looking statements that involve risks and uncertainties, as well as assumptions that if they materialize or prove incorrect, could cause the results of CEVA to differ materially from those expressed or implied by such forward-looking statements and assumptions.&nbsp; Forward-looking statements include statements regarding the anticipated commencement of Mr. Toquet&#8217;s service as CCO and CEVA&#8217;s growth potential and challenges. The risks, uncertainties and assumptions that could cause differing CEVA results include: the scope and duration of the COVID-19 pandemic; the extent and length of the restrictions associated with the COVID-19 pandemic and the impact on customers, consumer demand and the global economy generally; the ability of CEVA DSP cores and other technologies to continue to be strong growth drivers for us; our success in penetrating new markets, including in the base station and IoT markets, and maintaining our market position in existing markets; our ability to diversify the company's royalty streams, the ability of products incorporating our technologies to achieve market acceptance, the maturation of the connectivity, IoT and 5G markets, the effect of intense industry competition and consolidation, global chip market trends, including supply chain issues as a result of COVID-19 and other factors, the possibility that markets for CEVA's technologies may not develop as expected or that products incorporating our technologies do not achieve market acceptance; our ability to timely and successfully develop and introduce new technologies; our ability to successfully integrate Intrinsix into our business; and general market conditions and other risks relating to our business, including, but not limited to, those that are described from time to time in our SEC filings. CEVA assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>About CEVA, Inc.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">CEVA is the leading licensor of wireless connectivity and smart sensing technologies and co-creation solutions for a smarter, safer, connected world. We provide Digital Signal Processors, AI engines, wireless platforms, cryptography cores and complementary software for sensor fusion, image enhancement, computer vision, voice input and artificial intelligence. These technologies are offered in combination with our Intrinsix IP integration services, helping our customers address their most complex and time-critical integrated circuit design projects. Leveraging our technologies and chip design skills, many of the world&#8217;s leading semiconductors, system companies and OEMs create power-efficient, intelligent, secure and connected devices for a range of end markets, including mobile, consumer, automotive, robotics, industrial, aerospace &amp; defense and IoT.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our DSP-based solutions include platforms for 5G baseband processing in mobile, IoT and infrastructure, advanced imaging and computer vision for any camera-enabled device, audio/voice/speech and ultra-low-power always-on/sensing applications for multiple IoT markets. For sensor fusion, our Hillcrest Labs sensor processing technologies provide a broad range of sensor fusion software and inertial measurement unit (&#8220;IMU&#8221;) solutions for markets including hearables, wearables, AR/VR, PC, robotics, remote controls and IoT. For wireless IoT, our platforms for Bluetooth (low energy and dual mode), Wi-Fi 4/5/6 (802.11n/ac/ax), Ultra-wideband (UWB), NB-IoT and GNSS are the most broadly licensed connectivity platforms in the industry.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">CEVA is a sustainable and environmentally conscious company, adhering to our Code of Business Conduct and Ethics. As such, we emphasize and focus on environmental preservation, recycling, the welfare of our employees and privacy &#8211; which we promote on a corporate level. At CEVA, we are committed to social responsibility, values of preservation and consciousness towards these purposes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Visit us at <u>www.ceva-dsp.com</u> and follow us on <u>Twitter</u>, <u>YouTube,</u> <u>Facebook</u>, <u>LinkedIn</u> and <u>Instagram</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Published in PRNewswire </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>For More Information Contact:</b></p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 72.8676%; margin-left: 9pt; margin-right: auto;">

		<tr>
			<td style="vertical-align:top;width:42.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Yaniv Arieli</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CEVA, Inc.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CFO</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">+1.650.417.7941</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>yaniv.arieli@ceva-dsp.com</u>&nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:58.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Richard Kingston</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CEVA, Inc.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">VP Market Intelligence, Investor &amp; Public Relations</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">+1.650.417.7976</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>richard.kingston@ceva-dsp.com</u>&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">3</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ceva-20221207.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/10/2022 10:02:46 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:ceva="http://www.ceva.com/20221207" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ceva.com/20221207">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ceva-20221207_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ceva-20221207_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ceva-20221207_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.ceva.com/20221207/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="ceva_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>ceva-20221207_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/10/2022 10:02:46 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.ceva.com/20221207/role/statement-document-and-entity-information" xlink:href="ceva-20221207.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.ceva.com/20221207/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>ceva-20221207_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/10/2022 10:02:46 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>ceva-20221207_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/10/2022 10:02:46 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.ceva.com/20221207/role/statement-document-and-entity-information" xlink:href="ceva-20221207.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.ceva.com/20221207/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>a01.jpg
<TEXT>
begin 644 a01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M%>?4I2IRM)'?3J1J1O%DM>-_M'?\BSH__7XW_H!KV/</4?G7CG[1W_(LZ/\
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MPYMH)'W7.F,;60$\[1RA^FT@?\!-88^"E%5$;8&;4G39Z%1117DGK!7->./
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9#@UV0Q"5%TI(Y)8=NLJL6:=%%%<9UG__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>cevalogo01.jpg
<TEXT>
begin 644 cevalogo01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MG _&NC*,-'!X5+HE;[M_Q(QTW4JJFCZ4^&WA[_A&/A_IE@Z;9VC\^X_ZZ/\
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M;8S%#&KF0JI<N2SD#<Q)ZXZ#N2:Z*BBO);;=V>LDHJR,OQ/O_P"$1U?ROO\
MV&;;CU\LXKXVT3R_[=T[S\>5]JBWYZ;=XS^E?;4L23PO%*-R2*58>H(P:^+O
M$NBS^&_$]_I-P"KVD[(I_O+G*L/J,&O3P#34HGFX]-.,C[4HKB/AAX[M?&7A
MB$/*HU2TC$=W"3\Q(&/, [@]?8\5V]>;.+A)Q9Z,)*<5)!67XF_Y%+5_^O&;
M_P!%FM2LOQ-_R*6K_P#7C-_Z+-*.Z'+9GQ7$C2,B("S,0% [DUU/_"L?&W_0
MM7W_ 'P/\:YW3?\ D)V?_7:/_P!"%?<->YBL1*BTDMSQ,-AXUD[O8^01\,?&
MH8?\4U?=?[@_QKZXM%*64*N,,L:@@]CBIJ*\JOB)5K76QZE'#QHWL]SYI^/G
MA[^R_'$>JPIB'5(0S$#CS4PK?IM/YUT_[.WB'?9ZGX>F?F)A=P _W3\KC\]I
M_&NL^-GA[^W/AU<3Q)NN--8728'.T<./^^23^%?/?@3Q.W@_QC9ZOM9XH]R3
M(O5T88(_D?PKOI_O\-R]4<%3]QB>;HSK?CSXB_M;QXNFPOF#2HA&0#QYC?,W
MZ;1^%=A^SOX=\C2M1\0S)\]R_P!F@)_N+RQ_%B!_P&O"[NXNM:UF:XDS+=WT
MY<@=6=VZ?F:^Q/#&CP>%/!MAII*HEE;#S7[;L9=OSR:6)_=4(TD/#?O:[J,\
MC_:)\29;3O#<#]/]+N #]50'_P >/Y5A? +PW_:GC*;69TW0:7'\A(X,KY _
M(;C^5<)XQU]_%'C#4M7<G;<3'R@?X8QP@_("FZ/XNU_P];/;Z)JUQ8PR/O=(
M6 #-C&3^ KHC1DL/[..[,)5HNO[26R/?/CWX;_M7P3'JT"9GTJ3<Q Y,38#?
MD=I_ UY!\)/$G_"-_$2QDE?;:WI^R3Y/&&/RG\&Q^M9MU\0O%U[:2VMYX@O9
MH)D*21NX(=2,$'BN<!*D%201R".U.E0E&DZ<V*K7C*JJD#[HHKFOA]XC'BGP
M+INILP:=HO+N/:1?E;\R,_C72UX,HN+:9[D9*2305YE\6_A@?&-JNJ:,$76+
M9-NPG N4'\)/9AV/X?3TVBJIU)4Y<T15(1J1Y9'Q,DFK>&=:RC76F:C;-@]8
MY$/^?P-=S8_'CQI:0".:6SO,#&^>W^8_7:17T3KOA/0O$T(CUW2[>\VC"NZX
M=?HPY'YUQ-Q\ O!<TA:,:A #_#'<Y _[Z!KTOK=&HOWD=3S?JM:F_P!W+0\U
M_P"&@O%W_/OIG_?AO_BJ]ET_6;GQ#\''U:^$:W%WI<TD@C&%SL;H*Y__ (9\
M\'_\]]5_\"$_^(KN]/\ #5EIOA%/#MNTQLDMFM@S,"^U@0><8SSZ5SUYT&E[
M-6.BC3KIOVC/B^"5H)8I4QNC8,,^H.:]-_X7_P",O[NF_P#@.?\ XJO1Q^SW
MX/ _X^=6_P# A/\ XBC_ (9[\'_\_.K?^!"?_$5V3Q.&G\2N<D,-B(?"['G
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex_455178img001.jpg
<TEXT>
begin 644 ex_455178img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  O '@# 2(  A$! Q$!_\0
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MM$U$VUO:1JDNU%;=(>3U!Z9 _ UZ9X$DU:?P?8W>M73W%[<KYY9U"[5;E1@
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8E2=KC\L_E14XFC)SYHK<>&K14.63V/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140061293933440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 07, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">CEVA, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Dec.  07,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">000-49842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">77-0556376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">15245 Shady Grove Road, Suite 400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Rockville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">20850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">308-8328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CEVA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001173489<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>ceva20221209_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ceva-20221207.xsd" xlink:type="simple"/>
    <context id="d20228K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173489</identifier>
        </entity>
        <period>
            <startDate>2022-12-07</startDate>
            <endDate>2022-12-07</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20228K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20228K">0001173489</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20228K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20228K">2022-12-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20228K">CEVA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20228K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20228K">000-49842</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20228K">77-0556376</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20228K">15245 Shady Grove Road, Suite 400</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20228K">Rockville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20228K">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20228K">20850</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20228K">240</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20228K">308-8328</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20228K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20228K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20228K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20228K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20228K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20228K">CEVA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20228K">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20228K">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    "  *2(Q5EXJ[',
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MA1H#V#<YD 27Y*IU5%WI>:;7-Y-;2>C@W(-@[^&5C!W-CQ]W]P-02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ "DB,50=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  *2(Q5
M,+08$NT    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    "  *2(Q5F5R<(Q &  "<)P  $P              @ '+
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (  I(C%4_<0)W1@0
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M2P$"% ,4    "  *2(Q5)!Z;HJT   #X 0  &@              @ &Z$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  *2(Q599!Y
MDAD!  #/ P  $P              @ &?$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"  #I$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ceva20221209_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ceva.com/20221207/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ceva20221209_8k.htm">ceva20221209_8k.htm</File>
    <File>ceva-20221207.xsd</File>
    <File>ceva-20221207_def.xml</File>
    <File>ceva-20221207_lab.xml</File>
    <File>ceva-20221207_pre.xml</File>
    <File>ex_455177.htm</File>
    <File>ex_455178.htm</File>
    <File>ex_455179.htm</File>
    <File>ex_455180.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ceva20221209_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "ceva-20221207_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ceva20221209_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ceva-20221207_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ceva-20221207_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ceva-20221207.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ceva",
   "nsuri": "http://www.ceva.com/20221207",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ceva20221209_8k.htm",
      "contextRef": "d20228K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.ceva.com/20221207/role/statement-document-and-entity-information",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ceva20221209_8k.htm",
      "contextRef": "d20228K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document, Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document, Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity, Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity, Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity, Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity, Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity, Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity, Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity, Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity, Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity, Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ceva.com/20221207/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001437749-22-028836-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-22-028836-xbrl.zip
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MF +8F88D;&90$_ZY6^.\=PO3-,SB)9$ZOPFXO#:-&=8YV=1?_/P.4$L#!!0
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MFI<0,B :Y'2['Z/A?^,R)3,&)>3JH)=EB9$)0PRT,AEMX!=@.\4F*MB=%E^
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MT\F.0W@F"5;\\].Q1/VH?Q#CG5]02P,$%     @ "DB,559 &',=&P  6IL
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M%(H1B*)T\^X=?2QB8;$S 5@^0PB("MSL-V@U%1V"#.PC<-5FJ]K82OIF[W(
MNRL:)V^RJ;.IZ@5<$)E2%.8P5B_P8AW8%O[^D&??O%S\<T$B_KF;B1%)$?V\
MXDIR/P(N 8/#VYUP=2G]+KY>V__IQQEO[)J)8)ZQ2J89"WDYCKJL'<Y F@(/
MA>G'!OUGEPVY\_E2@0YVJXNOIM*-QBC#C7] NT#!2HRD[3([,0P9L0;R4-E\
MS:\_7P/^+S?G"EQ>KV/*U5."6691RY"V5>[)2YC6 ;X3*@=&&<)7 +, 19ZL
MVRO(FIO:SEP@]-YP_]>3HXO^(1M<'%ST!WOUX?ZC0#'H]WX]/[HXZ@_8P<DA
MZ__1^_G@Y$.?]4Z/CX\&@Z/3DR\$;17?WPS:[P>#GX]./ER<GE3888^U&IN=
MG=L \P!B^ W$XF:1^.KK>D@^>W]Z?LSNMMD>!DZ,^S<9+SC&=O6CH7]QCWWE
MB4?EB?L+.&B>\_[)!3OOGYV>7SR:GCD#XS2&'BP*V$ X& -@S38+%&MNKKL;
M+!BQ:"P>#3P *58RDC!R'QP6[E\*=N!$"%9SI]UY%.Y_R/6C#8>+52($'XBM
M)[\%!PM.Z(B)*^AH7PMWH\L();=0-2;D\W9-SJ*N"Z-.H-'8Y?,Y#"W\,E5T
M1@9DWQB6:_N'PA&3(9C&6Q6&@RYKIE>M],QVJGNX@^?B4FJ,(48G\,9HMOYO
M!Q5V=-*KE6]8CR!&Z_T9!ZV!(*+T9$ SKMD@% [Z:2X#G[TW!B=+J(W7??4K
MKBOB0T]8<-ZNP>2.\#P;*DE_ZY [R>^[\X59.*W;0%+UQ"CJ4LS%/E"$4AN%
MP:#3W_8B#/OL[T4*?N-/-YGY2JA(.MRS;!4%83+#=JWY#^H/[1^.A>^FT#'/
M@.&"2(0JN$*1+6IT([I'OA,HV#<H\#_ UCT3RNP%+NEWCT]A+U@AP+C^>N3>
M@+AA$$7!),&=05W"'#=V?@Y87T3J>^D)Z #[(L6$JIV=[<ZJK?$5A:4HO."S
M(QL[<X@W$WQN;54;FYMOVEMO;D8H_"6AOHMLIZKA03$$NQ,)']K<IV!K*_8+
MF+S:E62,Y_>AAX8+=LJ"CLAOBO?@78O>>_#NHQ&F%TPF4NM'I@/J%&:$X/LC
MP5'MO#:HL?XD](*Y4(])AZ)68B=!;04YK/+Y ?X: Z-.%M#+=%+OH>$/7%<)
MK>V?3](734)P<[/5V62#,7?G[ -8+@*@Y&Z%#6()^K'3:)0Z%,/]RAV#:P4H
M>O#/4W413'V"X3QP/E])SQ-E<WW11*3E3]49+$QBZAIG.SXLF^9+9CD+P/#S
M_D^&QHJ#.5J-[<URS#U65&?=PHJ^V)D"9,B0>ZP_$TX<2:#ZZ0B$3.@*X[[+
M8"D,U_(X+MF#HN5N9$?&/5""9X3NE))YXX[L]"F #>!L#$YC8GC!V.W&=G6[
MW=I^4GR4^?$(PD\_;K>:6[OP7+,+X8D0EV#WS0I:,EZ,#B=#G!%'/26&>JFQ
MA&\C*.^A)1C*)IZCF/UIM4J%R1'&<?Q+X;(!JEKVB>N(G5.0] 6ID3]C#>;(
MO#AQ;RR<SQBS9SP$[S^$SA'&7F9L*+Q@BKC!EX@RMEW]R$94JL6D9A(+9%S
M610P+2>Q%W%?!+'VYDR#Q:-'<^II.P1#@,$80B9'P%065:/2'=#>\^3=*/!@
M<NR'$0F)%K5FH._VM<  P[ZM_?% 3&&(V.0A#FJMFH%ZH_O@%+MOS*H@-40L
MZ:/=B$GWV7+@:87AS=#R7ENTSI.QMPL +UOQQ7;7V<EL"6\51D\J3(-N'^6P
MR&Z'QON$JH9!X TY< B@99;?BGY7,@*F1#<L]JW=K7'E.UN=SN[=PBH6*;=P
M9+X^4NPZ !NYA; PEWL[CX';.JU-*SHH,[G<%Z:\UIM;K/?^G+7:C1HTW'B2
M;L>KU#P!J1D$GG2 <?S+8]#],*GW#$4F6P18&V85RP+3[/!JLY63F4*2.)68
M3J-F6KX*S:O0K!":,R5PF\'Z4:J[05-(@2.*_L^S$QY83-7)K::X\>@R07*K
MK?7AQNU$R;1]%:978;J=,!UI'0OU[$3J)E?K[E+6%M7.NG,[*;-MGZ:4?3U_
MMKCI9R:O\2:% G\T+*M1(VUEO4O W?-Q$)],40.SJ:$TT$,98KNBJGE)42.F
MP19SF;H<KC<J#/^[\>"IH L\*F0JWYPQ<SRN]9W28+E$^!U3Z,\+38I3C',P
MGPP#;UV7:(]7)"5E8,1*(E' H%2F8PE/,LWSG,L*[A3RMWIWWFP-2=#6]G'[
M!HP,HL#YO)P%^WNCUF@T6<@5N^)>+.[)9<\M'7TGG%I1-)*X1E617U0']&S1
M=@$[]'VL2Y3,Y=JUA%43P\F4G9X<# X/_F<ICTKLRXZY^BPB]NE3[X7;4C<9
MK$>^B\:IP/.U#N4)X/5G4'N"ZHX6@OA2,^XSL&QQA$MVJ8)I-$8;-\3 /M?,
M%2/IF[)9$[YL;"86V4+LTI3KMU,#]Z<?FV^V=BF2F?2!V8"@(=;>8DK'V,NM
M8;55,F3948#%L=&$SKKG1J^]C.0/&7[%:?LK2/5573M3;)!,]8%FZIF);O+J
MGCG&RT5J=(V05$ T2B5.+F7,QB!/P@/G!N3)#\C5B;6@5@"!S<OA51W2I [H
M+ 92C>;RYCCY5,+42' ?5@AOE+B2&OJ!E'+?P0 J=^BV FR,]R>X7+G:9.3<
M57Y6>YVG?E9>[FHL)?8+SVP_R$'DVQT,_B:"0L[4V[6S#^\^ED?#\KXG'1UF
M!><3'ZWM+XSU_N(\':SL)')N@H6^XU$5A&CY(;K3[.S#R:_'"ZLH_LG3Z^S@
M0[_Z[KQ_\+%Z\/ZB?]YEW)ORN5XD0F&U"9%;=R)R1K84!3\?EJ, \7AO!%R<
M]C[A#3_7H> FB;PQ.+9\Q#Q_<)PM+N81U2]6949BPC9KC5:-'0KP2*)8D7=W
M*!7HL$!I5(4]L(@YV"FFLDP!!_0]J^'R37?901@&TH\HG =OEOOA7B=\S:'Y
MG!THA?H06^NRYK477FRRAV<-]PMHSZKX?@,4L#,E--V$@>]^#Y3G N.#,<<]
MH;'PXRDAB"UBZ#Y7+21X6KAKX=1GBP<F*[2GO@M@$R[RZSH^QVJV5F.77M._
MF[NT#]O3=;Y3*[2S)EC:$BLGC[3FL&$K=@J[-J_8+7P%>=;M0/W?SO+3+9 L
ML03L=&!BP Q@.H -1#%MLBK0O #3!@#'?Z'MK9%#3-'#2 63_!"FR#,_)OX^
M5C4#-:/]@IP,L$HXV"7I2-CN'&PF#G;2P:42)@:?1TJN<=H@79R'6668F$?,
MY?."\6/B0"D,MK!00Q=M&@,60%->(0;!;B.\_G9V"W1-):CPH<A8H=TTO+ *
M;#QJFT#\0AR7\E1*#OO&V5NF'%K36;B.3%^K;I7A DTL,>7 W4I7EA%O#=T<
M<Q5+TX;"!X\VTEVV+E&"&)^@M<S$7S'8S@295-$<.8 HBYR-=[HQS3T.NP%
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M,=]U>K1?X449L- (=AT1Z11[2SMQQ4KDK:01N1%C*LHEDJ6:"L1FDF[^%DY
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MC>%4L.\JNJ3AE5[O-!]>R>_-8C3"D"2H\E\X6/:P*1N3I%VP>L[ &@R^J]@
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M])V>B-?P+4O4/AT,+JI945=IT=E7+29+@(!_6+*.HXFW__]02P,$%     @
M"DB,56*3Z3R_,0  ]/(   T   !E>%\T-34Q-S<N:'1M[7UK5]M(MNCG[E^A
MRYPSA\PR#I!W2+*N T["G02X0+JG/]U5MLI8'5GRJ"2(Y]??_:J7+!OH[LFD
M$\XZT\&V5(]=^_VJ%]-ZEK]Z,=4J??7C#R_JK,[U*_WY_SU\]&CGR9,^_/KB
M/G_YXP_P^__:VDK>ZD)7JM9I,EHDY].F2'5U4,YT<E)6M<J3K61G]_[.]OW=
M[=W=9&?[^?;CYP^>)2<?DJVM5R]FNE;)>*HJH^N7&TT]V7JZ(=\6:J9?;DS*
M:J;JK537>EQG9;&1C,NBU@4\7>M<SZ=EH5\6Y<:K'U_<YU6_&)7I(C'U(J?7
MBWK+9/_2SV'J>;V7T!<3-<ORQ?/DK_]LRGKO/)MIDQSIJ^2TG*F"O]Q+YBI-
ML^+B>;*=%<EV?R<K]I)Q4YFR>IZHIB[W<,XTN[0+TFE6JQ%-JG*C-Y)4U6I+
MS>?YHBYAM?8+>'5K?E$TLY<;IE:5_3[-S#Q7"_I^1[[#Q3(86FL,?L?-P1NP
M.?D21I#-*_EF7NE)]OGEAGRD6:-Y3#,)'ZCU9SBX[*)XN3'&C54;K_Y:C,Q\
M[\5]V.^K'W]\,8_@>R-P=I_$I:HR5=3/DP+/.=]+9JJZR H ^KQV_WN*C^.B
MMFA5SY,JNYC6 /\7HU?#S]-LE-4P9G_GQ?W1JQ?WY[]I@;V$ONXE1E?9Y-KE
M&EALOC56<Q,MN7N9%GBK5]9:TIZ?G2:/Y@ZF#B;C@]J3M>!+!)XS/5= G$ X
MB2K2Y!1(1AF=#"XJK6?PRG4@^Y_6ROYG[=+D$*-%7+_Y/QIOY! R8$3XQ(/'
M[7/YM3%U-EG XLZGF4FN@U&R64]U\M>_/-W=W=YSW]+GG;U[/:098'X'>JQG
M(UTE3WH)LCK[7YA@IE*-S!%''^GZ2NLB.31&(=]+CJ>J4'!2"1[%ILRR*!L[
M/KVU/_QI #-<ZKR<X^2]Y+ 8]Z.%[9>SN2H6]K5^0GOSFX />C)!)GJI$]@J
MOOKTA6G<D5SJJL[&*A<HU>5\+\\*O375B,;/=W:W_QL@5D]?W(>77L&N84,3
MP+D$%IL8>"7)8%WSJKS,4H '?IN6<#YU4NG+\I.&GV'WP,\US*UJ&@ XJQJ/
MRRI5Q5@G5UD]A=,@/I\\VAS=2\H)/!MM(]SRT.WG ([ [?P[QF? HYT^T?1(
M%II<_T^ _PC'/F'B+V53);DR?$YP#GHVS\L%G0&=$YZ#X!SBED/_!SNW1RI3
M,U(QS41GW%J<1^^?IQH>JY*R(AQS2!CC2\^B>FN<7K3^JRS/+>;22+3#!8)@
MDA6@P\S58CS5XT^]Y&J:C:?\0E:,\X9?L,]=J0LX<Z18X-&(VE6CTU[2%(T!
MDKA48\]F)GD)'XJ+9%KF&<#8P(JJLKF0>9?6FVL#(X,V > $+2.IU6>9"A<+
M@Z"R8OK &%:2U,/^0SQ)&G_HCS,@+F62%'2% I4YX#57][K@!/B ,%(PT:QL
MX#7]SP;V7I<(^ZI>))L/MN\EM"4[VP@9JE&YJHCF\TPW3-L:#R^#A58P2%:Q
M$KEF@0%F'/&+)VH1LF/D>SJ)?^-UCS0S8D&(@%_N/-DS<("5059UT< J<9-5
M"2\A;Q<VUX%%_62PZJ>>X!&,P2P0E#"#:\'-&9U/$H#U2"," ""9N#2\58(F
M-M95+U%U75:%7L!?%XS(E1]%,1>?1*<#K#7!?^=--2^-_L[YX.YOX(/ K8AJ
M3M3X$T"=1D@&AC5\."(2]("_JQ&4=8&C\I*9X0YRM.U=Y@AP-*#+%RD^B-2N
M*PTT$PFTCB&]GI$1,27ZLQXWB&"1=.W1')6>*92I-?&?FB /G\> (7GF&4*;
M1S(G0US$G\NF!@J=935A<X\6#A"89 CW#& -)$[,TL#/QL%C7F6(@'94LRPF
M<(4P/+""-I^Y"3O&)R9 D^45+M2XPYKS826;8_B1]8%\P0,Z&6*??0VVZB2K
MC07J\V^<1I[LKJ41%=/(\G]#DB"\9.7@/#@L,U6!4/BOQSL/>X\>/^QO;UM9
MF9E.47$%J+][+UEHL/V=G #[ND+L5T6!SX5B8[/K0&.N[U=K&?Y<9>F2Y 3M
MM"&!N"P^Z0MZ"9:(^P'DYB5G!9C-><Z8O4*$= D/>!@6E:AD#G9EF1+/CK:^
M4K@DUABHHZV=T#B>*WC:( %F&@#Y7.0>[62MO+NAG/N^R61T'9F\TRJ'4S@L
M3$.'Q%22D X]$I:3D&.L\R@N0.^;)U,>!*1,81B!4>QD1:/AU3K+Z540'U;L
MS^#7*2(HDUD7!I5C=%AY+46Q@.HA_W6&&BA<O*C"D":* NQX5F2CQB2OF_1"
MUV 2PU+&&8@0&GLPKAUR[A^_/AU$MJH;+]ZD)>UHLYF%6#*'N<<9.F"<W@3T
MJ^$T,M)V2P\-XA1+ S@X T1 ^\7]EI$0P;71JV9>-BB#X/,8B1/VF^JY)EP(
MI);,X,8--51GI/9WQ4Q=K1+PN1.<HFW0W"BX4&_S6N'-5GD;9%JAP_.*4MC2
MN,X7W>H\G NH%%DS,_$899.GR51=:L=B6,W7( PFM"'B0VZ+4\4. =9/=$JS
ML>EN5=\0R54%%@)P)X#KYLX]^BYDFB@>X-7*H%P0:FBA_AX]C#\09\.Y1X#$
MLP"E<)5+6.0/I2IGP+4+X#6R0C(UK8V&9[7E3>(]_&WS06M&5:%YD^1E<0%O
M=^*RFR_ DG[R)?DM>;#!T#<O-T[>OO[[AIWR*DOK*3)4L-"%=6[E>E(+_Y1O
MR,5)7SEON!WKS?FI&RQDK>*I3(()6N].)UM5>;7\Y5@#ZIZ\/?KXP;NZ0<OV
M?NRVH]NYM=<L8WV$H.V8W7BU(T[P^)\?7TPK.\O)X.UPZ_7I</#WK<&;\^'I
M<U#&K\ :WDM&Q)A0(A4Z L!>(@Z19'?^>0^P(L<HPU^VZ?_@/5!QD:Z+="O^
M:0GH[PZZ@8XG]YM!?GZ\_SXK/K6B "O@T"V_EY#V6G_[2J\Z;N7KUQG&U^D,
MY.EZ71:-6=:IK_.SX#--0:P73#>TRBXU&7FZ,,P#28AZ+CU"EW/(@("+%H$0
MH<4<NJ%H6<D)"(]([3Y\3=\Y:2^""SCY--.7:)6!+"DO"H JFJ*7&CE<#1#4
MM?=N!8Y"=O?UDS.4%;Q'$ZONK(4O.[_6J/"]+J<R21!=S8P5%[*5[URQ3:]#
MTH?;.YN?[C$F?%"?]-;/ &;QBRPC;-MB%S,$SK[$>"+@!T#_OQX\[CU]\M">
M*;H%NLZUUSI4E+WH\;RE58EGG2,&@C;AY'BX*Y3$%>BZ[)=%[P*Z>-C3<@5:
M%QP:[DW>;6NW/3)1 P4H]'/.9CH%C5GG"_&-B$I%^L%29$/(P,$LHH,_R@RE
MZ1O1DY8U)[8MOW.BT-<1Q1#L@'H1A$FL:;.ST]MY]AC8ZB6@&V %^M^V&$$J
M^*;*QOBMJ<OQ)W@(;0IK19V>?70^*=#@%683"'LFO(+?$W6EJC3TK]E08MO%
MAJ@;LFU\>4 O.V3SDW$D(T!57#OBVZ2!'P3#XD ;35*B__(J,V*.D1[(S+@<
M 5 5,V>453 ,&0.XQY9="S\#AE\@:A:>MKK6*[[#963?W=[92<X(I%Y^+4FN
M4&SUV2Y_V'OR^!EZ92C#!%Z5D^HZGI.NXP$8O=&CJD%:)_E)>V/PL1TG] Z(
MAMB!?P:L+I@9(*!R0^8"BU*,&3&;D\]D2+*G;81<$F595BRQ(P>5UR6"#PC\
M@,R[$ICA)CIG44F8976M-?N?R\D]W <. ?(R*W O8S)%/6,#.PTY3[A>*\LY
MP@U;[75OF9U1UVR4@D"DR.."$=3LJ5BGOA"4Q:BLPM D.L09..3'\$>BG#CP
M[%<OP\E!$,'E@&6_O>= [SAH>$ RZ-*&^\G/* Z!!\QA$E%J*C&&42SN]IX]
MW?9\@V#0P05.;LL%V)D38"EI7-OT.WR;[#RE+W80M6!U*YA!-Q/8!%N+W.T8
MP1J#G: #L>(9'XZ CZ!V"E8/0&E2LARR7),=HT"6P\]C/:>3FI5I-LDL>L>Q
MBG7LYJH%9L=[0L#>A 4%=-H)=,N-[G3(5Y/^LH1D]R?\N$\6.^;HD5 -GSD,
MT&REX[G#=56#&DH'6VEERH+." YW3L*F!J(Q$QF+;%=*$!3^8KQ6EQG3, \_
M-)72>;+YM[_];4O^]S=V9 IC_ BB !X]JTF-:CTG80+KPD-DQD7E26-T!V"^
M<52Y)B3[X-8AV6-*\=@/+5N M(WB]:V7'1C0IZ*\RG5ZP<E%/9! EIGHSQ@T
M-_G"N[RSY301[Z\#0Z&@%->43>TTC.*/-3) XK%IFN&"5!Y;WF7@\B<G8L28
MO]<(RS68\? &F"$?AI\1UJ EZFPV0DV%.#*C HI9/MNE-)25*1K$U?&D33,"
M:1]F\Z3EN)E19B\B$<U:A;,"'&$8^BL4AB* 25EK#*AIQMCWC0052?:E3H_J
MBMT@2V$=D%*;M/[4FIQ]'#BC*%UM)9!"*HO^LJ'NQG&\BX2D6^,<?FM402*4
M(Q]L4+K=S"MTWH_9$I!I[ES6MW)9[WY!E_7NG<OZS^&RODT:>$PE4;X\/AMR
M7V*^Q&<?W5P"RP>N[LA=5C12_,\*HV_][R!W_$;Y,ZO\1)B*"6K(5!42Y(T3
M.:P6X]TI:)484%!$#%CW?*RH $_V8H%M9%1-O#\&P^:BP'!2F%>%_$-&DR'&
M"00=NA#ES4HX5Z+;-CS=:QGY<S2(:ZG_R=55#QE#97J2J%;BGRH%FSDSH)[+
M9X.YNN2K-TVEZ2O)=PSAP=JT09V*MD3Y 8K%+'Q'B8Y5+2(0OF\'HE>GA UM
MU/E$53BLSZ=!MPALY(+Q/E](!!Z>UV2K5$P(N [T W(N;XG1CBI),X,Y_:2$
M!CYBS-[GC/T>R5,0]*BS]%#E@//. !]I8V1SH*G*,,*/WM;,*IL;"K^EUJW3
M ^0MU 5].<>R'H;E!8\?YXOBD<BV0WCWV/I'5SL/ YH)Z+G&T/"@&;B_ETZ-
M]1Q8%6:&H'&T7(_0!C#Y3!!D%%\/5"5@X-D,QH:A1C >GW6J87LI_"$U5AP9
M4#9$,%8-ZBODAN%<10-'0H^;FC"0-9I@MZ(=)1,"0JIFF+&-.X*I"C?K"-_^
MM4DO9@S(7%_2+XS2+NX4^AXP11YP8)%\RBC9$\A2U0 EBD<166CR&U,HPQ%B
M#P0L$"%:+YP6WA3T-^Z$W!@ZE:_=YQZA65X:]Y/[#/NL,D/4T9 ["J;":!@J
M?HI0EQQ"2"S.E]'#9=._ $,B-8 U1F$HBQ3>1&>.#V PDMIT468# I,5@8TP
MO734L(N.TDMI)<^]DX8Q@&:0<_?9*;01GZNR;I>P_((!Y[/XUQ4O"&-N^?7(
M!1DF>,CJX&F[N "<'/+!P\1,?T+ V2PSAM&47,KR3U+.!7DE6YLY'1PYT-,T
MF\-.8"7  XSU/S@VXLH'Y@H^3:H,Y8JU-7O=)HH)@$\C%QH.9%8"B;$L!Y8,
MS+$7Y=,N6HM#;R;")+1S'4!"8V%=98%D0/,BE%C.S%'8>5KY[&CGG.Z<A7+=
M-8I)7'=-2%<E>3F& 8G0\#O*D$9D1A;A.00(<Y 8^-B>H'J-M@Q^D6PBAEUF
M:<-LWS$R7(&P+Q$&7JA$#QD?8B";BY=N/0LL.-A"!-P$'8H/I5WA)&4E/2(6
MZY((".8+JEQ4SRHFP,N-[0URJ4E=K/MLYFIL/T>&&%D)MU!O-ZBF^(<7=05_
MX+]I/-[C!]$*Z[3]6$>QD:SDJ0P/C_^[X/:79X^?/&/ X30W6]ZZ-?V;5-LE
M/1;YKZ J*JFC2BM@QD3N3!R]X+M_-H#"6_Z7.8CQ#-6#18)ZRWR.O"35=94A
M+BOT-7#A >LS?B#D;!E6)6C.;RP4!U NRA*4 X5,FM0$E2'#I>R!)>#"OX@J
M8,@1HMY1Q1U5_*%40:)B7_12+T<#8IE4JD&%3,/JI%K&Y KM-E1D1T@,A;Z
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M?_8@(:JRY2FN>_H9F]MAADF/_^'\KI'!!&'.DM0\;E!H.G<I)*;58@!-;>N
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M2_<PY)GT4W&-<4#+ -"5,\U.*<P.08^\"]9CP\*4(ZWX,':P)R:^<F%C6R6
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MC3QLC".@9=G),#DP3&!VC1"U;?K)TWSO5L_NS?G849D,4AN;(@MZ51LT7RY
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MWVW%-[FA*,\*VXX!$U1 /E%2H<=G%F,\,]98<^M5::?9*OU?NI^$0H),]#,
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MUMBT%YZK[LCJZY8R1VJFG]_@D&*F_V=%USM<_3/CZCFFK7ZGR+H_/+Y#SS\
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M5D>C'F%%8028*O!^6%FI:8'5K+.( ,P2-87WKT9Q7J 1D1954M8SWY8(2)*
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M^,/@^$*=O%5'AP.$K'IW-AC@5P]T5_J@ Q"PPO>H2Y26TA2/LW3K,"[")"O
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M+E&/Q^#2B,> 55FDK:P$D\&3IUV>U&*BR"&J%-N>"M@V<Q3RIEUFG_J/A6Q
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M L*$?ZORN(@D&[J84 Z6'Z$73NHR;ZT'Q]L%=ER*QXM=.#V'*6#13+*7YX$
M=G7*-,*(<B2+84;\DX1@\"EJY1;=6OA&X1I(\Q/=Q"VDH-O_.@%!_,+$#2AI
MH9"!8\PWJYOZDNXA[ PCQ>CJD@R1F@D-Y^U>MM31F.6L)*QVB82PI\%*QXEA
M5A [,_UQI6/ ;R!;R:-*0&E4J$/X*>CGY)TK!=$=9#48/:T7TQW9!]!.85$,
M<H&ZG'@ZIP*Y0X7W;9B,1\]/;H&RZO$3U&-,.]CC\8]E/E:7M7X[SF):WE'7
M[:W1-G(YXPB6):K[8DK ]C4'A[0$*1C:A^,4$CL*VKGIMCEXWDR1O,EH0H_6
MZX_ .9CK@DN?Z'S:\HKT+,]K95A2QAF*RB$EKND(V +R6\P+CBB]D="\Z\ST
MN#;4;#,"UDES>=L=O8(8!R$E19P_,^5$!EBNTS3B]+<J96T'3.38C"RLPS5\
M&;%WQJR(6%@>Y&O<D0#,#4S=(I.6C22)%G+/&XP3U"JUC1PX>!A&0F^^GFO8
MEP62$)VFSO.IIH2%CJ;HQF6+L+RL*(UIEI*D%YD18R\*Q*77B]"6.3)TC-LX
MMY1Z!V0OR>5/^-/-?@8"_[GHI5.*\V7K(+2RN)P80=&-B:9:#;,TJB=3V YY
M?7 [MU[*@IAQW W,B=*,0; ^_57(B]7I+&]0#5O,3:1NTZN2MG)D;-=Y1^Z<
MV>9@?0BEK"B+)AA9S;@$A\IU!QU1:T,BQ#HNLQ@%3,1DT>:/%K[3:3DH[A<@
M1W2B*;ZG\8= _<ADL;NS2(36@E( I,BEYV'%])2*N+0\O@4I@/((1;5B]817
M9\V8/T637X=WUN&=!Q_>N07>IE<WJGY%(+?<>CY \==Q(DDQTJ'+=Y<ZWD)(
MBM8YQ0*=.N=V-!_/E'(&3L<M0"CZXFJS'7E[' 4]S7 T(]'E+7BUK-9;T%W2
M=Y&[9NY4@\6#PH"7\+XCUX38@>B3P&'4Z!F\/,3-E Q0 7B397&?6@&C!WUN
M;*)';US< M?-(\G2=0G$]X6SLQ1H&S<T!*6?KI 8?2E)S1R$:.=.!!VQU8"$
MJFON;IE2W'$3DY.PX]6R5=2B'K7C8.BG';7J"&0![+?G8"5'>(9<9>&Z)><V
MFL@UQ4\W0=;.2<YSN,25 ;8FX:M>UC?1@N3T_/YU+6)G.SS\TVM=?KVA@NZ2
M'%)FC?-DM\$A/G7+=F6NA5<+NQ D'W8KU2E9=-8#10X-/P.&D,:Q9U8CA9QX
M%:4^@77(1YND>@U?[WQ;2*D5M>NBJ$).M;\E_25T$&>U<ASJF0YC[NR4F*[J
M!DL+\WC8 O.]1HG37$//FEAO>$IRP'O"?[;<VCCR]N:_14MJQ$0+AC^[Y!D"
M9^$F[.0F;T"F=-X(NGG2]K8.J=$9-N:6BI2EUG2_BYG"O)@]V(EDM7 S^&]%
M'9N;S;N[^>@Y]RU@_7QEPBLS.A"DD'9&L.^L[?48U0XCSP'-A>+]CL4_Z%SN
MIB8W#&$\H&5>,3"N6&)1HP$EW>. 4;*\G;_K*QSC2F._"%:@AE9*22FEWX%-
M*D^)]W*U3$>8."=+#6*T3$1I$9;XX* 3(@RY_*YI%=\4)[6;(TV=6K90J#WZ
MHW(+'"]W5 ;4?;$FN2?[\/^(5..^&*0#,K6MI 57F?.:)_$0_5L<:<1D"$D
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MB!T7:IZ)9 HCBA-8E72CXY@H:'0[)H:F7F<Y.X VUXU:B(ET&\^3&3(&,4*
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M3_(3>9*_")X!Y[U"E74%E8@<3N# O4H-\V(8-R'I2]U$>"$$?.HRD?4EK4[
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M^IY0^\'AE_U$'%5I5WR6M/Z'F2J\_%U<F+\WR@OIQ$&NU5@<F+)4-M7P[A,
M*U66K32RY'[TG]X[M:8T'NX$[REK6<W%%#YL927D&)\"D)UJT[AB+@KX+4UT
MLL"><+[]T_T#DB/34L@J$X>--;425DT0 =RPI[\G(.Y _;\USNOQ_)K^STQZ
M.=5%H1)Q_"X1[U2JRA%TU1\D@J)G4#+@N2>"$D9[CWYZ->CW=]NA%0L^_KQ_
M_F[__W8$C3U)A,_50M,%3%8Y8X49BYFV"*3.492K*,A.M9^SVAWD\\)A)MV#
M )Q7IC 3C9/3Y=1T4JLD167A3-'0%X=]3";I_LHT58JDX'/I-X&4 TDCI2J@
M@%!"LPP+:$VA2*C;8"8>'QR</.$9?%*K:B09$B_#,5(/-&$E70%S-'AP>)*(
M_5);<2JKQN6)4.,QGU&)OV!$VKGHLVZ?=L6Q[;;RS6 $H-TU):'.U3@8XE%!
MBD%"XKU9\2]W740M*P1F1=ZSPC5I2AK%9I#.B9FQ13;3&>PZ-D5A9B3;D7.2
M,I\XR64E%\MEJH;6&ZO$&+H1N7:B-DZSEJ&UPRN5-BS_%^A#G$(ZK%MY4LG7
M=AMQSC(MS[I TM-PVD'W'CK0!YP<2OJJ+)"$E6Q"]F^Q0F&HY"2.- 9E#[9W
M6U 2&BDS X92U'IJB+4P$A&+UFT=##MN"J&N$-0<6063"+H4M$366+(M66VP
MC44;)^8*-DZE55 _/('6ZXI?%._*D*>T)]PE(.<HQ@)(&@O3H*X 9M-8,6K@
M@H2H59@Y@CIY-$\),#1V(BO]>W#*Q>T5-"=J;,B^-;%FYO.N. (NFP)G+AS6
MT9<J.*&L+I?8)+33870UE45#Y(?)D-4C=G>ZXR8%"3/%:>ETM72>5$%:".+/
MM,NQ9HE]"YXR4HZ.RON,&X:^ H>44V-=ETW5_R:4_D/ANA)N" JEP;E)^TMM
MP5;+X()=Y401@@EZRFJ%Z-H"*L'M4"(B(*XC!CIEIX1#K'L]3(3@0):].<]V
M:7K,S8F @5S-=Y))^\^C;+#7+P8[?#1AFS44?'-/IV6R2$1L_T876<<T?O.<
MN(^N+W7@FIK"_2;*@QLQ.4@@+%(/Q_Y<5]CI+Q(#B;B0>D;< ZM\A*9E5[Q5
M8U+Y;T:'Z10C-&E_&]EVU3@*/N(43A^C A^>A4J6CIEA0F%JDCNAK)8UJ2>J
M>ZDX.]&^B[D%/E;/"2.^1WC(:=*[\U.>?*&NH-6CRGG;T"2WEI]R4V10B3@^
M/PQI@C1 D[6'&L^;^M%/@Z=/=P$2>'\6[7)8(!M84VDL 7F1$BT\[O'1^>'I
MDWN9#]8X1[+""@Y.E@P"M=)J3C@2$DG78(M 2D;P,8!.4^*XG97$U;KB!/HF
MOFM53K0)J9< BZ2OS3_+M1*^GBE5!\?WVJD >H,O&;2EB79)"IM7W@)2" "T
MS516P:46H3NZ"M2!8$'..$9TAO@:9&T:O(GFYT@^Q&+FN%A2%E$3N^9K",^=
M@&UP&\711E$^*8RYI'5GTF9M<FK1[U*8"M]OR568K2H6DB8L4ER$+B<=736(
M28L40XNN19V0UX2W\C>HUMCY#T@>W"THP!S?;)U^>/MQJ]T2K,SG5!=O_ZFM
M@#N%&OM8!L<1I@(\M.@\M&N]OSA;++9:-,=*3JQLL'%O/NY ,=<'4X7\>_KA
M\Z_'R[8"*.*R9[#95%BT$+XAQLT]@#_2/MC:Z\>J>OWCX3"W[8ZG^Q\..V_/
M#O<_=O;?7QR>[8!#S.3<[8J1L9FRU&2HU)HR=A&_@U8']17AJ#"8]M,V_\-]
M,KT$;AH >OW2-0/\\NYF Y 5_VGU7YP<?-+5Y4;WY18]W-R2N09@Y#H:2<@M
M]?@&D]S:@*&CW%&LWJQTW\<@\0D1@Z+".45ASG/_J-US!XGB@HLL2T&%XB;1
M9(HW%%?;:-8IHJ!N(6@H;$&,33$E%N\N0TRBJM?2S3X$;PJ17$V&@K+F,CG>
MS 1G#HO >9!/< I$1:(/4\7IRE)-FT :XNFI;)R*7,<UA7>+T@;!,],H]NQB
M):2 R LH22!OT.F0P;"Z+NM"AV8M0FG^K1/2<5:$[@9HB/>WWP&ABP;<8F4(
MQ R36[('L^A4U]PN#A59NB![2X*SK">(R!+/=9RU;XOYM:'^+&5D+I!R*$!5
M$P72=)%'VR3KAMD\6S#(JJ*#1A?4L-5Y/.%.H*8I]:4X/S<Q14;2>G#RY>A=
MI_\:!1!JF5*GNR%S7GD5LS))"-'C?"R/JBH-LD N WY!.III2FDW+<B+T!48
M5()L8N]%VB3(5-2] /M3)1\U3IX49@0U*5PWY5Q,N'</N 3Q9&QRM, B-@H4
M1G493[1@K0\$Y,74K");<D0Q)ZUA,@L.9 /S;Q"G.?O'! XR@<)">5(<[JC@
MTI%4)%'+-!PIQXB\DE#5DI0C<[&<'@H'S3[;DHQP<=D\P4+J2CO>*]X8Y&D/
MS5Y$TB) \)ZQ<?DS,&SFLO#T5 &E0^F2365%PN^"TX+RA2/1ZIOJ0EVM42NT
MXDGHHO82T R+PH$WD+1*%1,^-IWV^8?EZ1E8W.NA>XBO54P1,\#!SOD8J$(6
MFB-H@)!FO$O2(@)BU:U0.&65K5F!*B_$%'@6U*CA-@0)JD""6S!@6H NH3*6
MQ,.BA##$HHG&SM8RR+:C!CVO*:N4<^1SWY96M!\1X-2'.,9K_%'%9X:7NE7Y
MUY#@-?/H4'6V31\,+(3A-HWG[15C=W6_:\NMK=$R:BK9X/2@_%?76SV[O$7T
MSU9@F"[3,48LM!Q2#S)7./O&.BM6I'+5LQX*7>K0=4UBBF!M4@V1*9=:/<+%
MD$"@AU8?Y$*T]/GA@1AK8O,(L!PG0JO486UA1DBT"T[?U!F=D]K_W\@SE)6J
M\*2/(3G+-1*3JY6\)*L'1]"66[&QHTG+NOM8M8(<[8^H&;)LY?\ 2A2Z(>X[
M/33@$"##K=2V=7),'W%MRH+4V>Z*KXJY$76XW^F)IC;M.8Z CU-KR+\XV.P?
MH92<$/B3I9PUO(,01JG1SFMOX(!U/E_);A0F"P8D/15P9NQGY \DF@OG'C>.
MX:E+.:$B.)>1O"1\<T.E]%2'.5-#M$57=6QKX61ZK+EI0.Y?0/5$?9B@D/NM
MZ<E2GQ8J4!1C:.V1KH+*F Z0#RXCQ]'I6HD>&9.CSEU1M\%PV3.66<9,-W@4
MMPW#R:\"1P"68"$$F32*.@G/]E-MTT93-'90.=F!JFP$@$_<&IO<&'8#&T-B
MB7>%+G="S:]YF]_8M@M"MW@62!0'T:Z)&20V(T)*;I<^.3P& @E.E%YFRG84
M-60TFV2I9D^U4$I]Y9C^(JH0RTE3$7U6@C&24(K)Q#4B4AJ$<[5D5F =C>=G
MG%.,6C/"MY3OX+P+2V.&LL:!G2GQ2)9@SID:<VZ.!.8^QB_J@($V=HBP92LN
MWE8&"T=DM8/&T,01*:0./AQ)7ZONEO @05A)W="4GA! M=E4\O-%\L:VR;3A
MAL&R@%HJ83#9"1VFUO!DP$R;'KMJ#YD%R T57 %.BCPUZS"H8I.A8ZI>&];H
MG0\XR#)XE;A'PXE6:6F7"J7-V$$N\@N<("7"+S[)D6MGK!Q_S8?:B"?%R!J9
M+7&ZMO(R8 5E49^0> .JV<:&"JNIX+Z/VS[G\:^Q._9D(PZWM&R)_%Q)2XJC
M>+K\NG_6^W*6B-.#5?!C*Y1BX1F1*=P"Z*R*13#&2-#$.AC>%BC]#$B-> SE
M"Z(^DWFLKN@L)E-/$O%5=]YK\:SWO/="/'ZU/>CV^U5/ICUYA8N_LNGH&2A#
MZO&O7]]B]//;3@NC#Y_/SSG ,MFFZ,=:I;<0.+VI;#VE+26,A4A+J^^C[[99
M'ZD8ET'UN2%+:E/55*.NX^Q(%):"8$J/B-HBB1PR#^5R)* ',!?!]&W[V.,@
MA//PI,F#XL%#]KF?FQ.PA"KI$27U0&C&V"!G45&[MC6W:9#A(E&T*IVG!5-;
M3B6J&(?DR1)@P<+,54P6-4I1F<Y%?&,BDLR9:M]!H+VD:*L(HCU@^I"P96*8
M26M3TT+[^,H"E^G%QBL""3?<E0N%X5+<1?'%BF.5>$.4F),QLD+=8&_W?6GM
M?6A8#WY0PWKPWX;UO6U8_Z-0^04$ RG5T</;8;,WF\VZJ9K*3N;J+D+$L-?L
MQ3!&[_N($,HP\6)&P</2]81^_]4T%\U()7P#?K\'61RA0EY,('6K[*A:K(@Q
M>M(KP<MYF_N8B% $GS:C0KL\E$"G9UC>$7\0W_EUT#M\ "*.Z?V#HV7C@S*D
MEZG?63DCOW <H\6;K>TM06X87U1>_*82H_W]K[^V&T/#RT'WU8N7+S;#_^OK
MX9_J('I7^L'#!P^&WN(+?6:M*%/BHJ@FH\&]J7?#%L\&W6=_XALQ_TX4_5?4
MBE.Q;[4J=%#HG6VUVJZYVXW>G]SQ#O_;[[YXOMU]UG_9??GZ6?^.=T,\FY.9
MNI+-].?-,!K<<<4I29*>S_XPS)Z_ZKZZ6YB=:7I9+A,?J27J375?H/;E5!R'
MQO/12L^*MIZB>D4$"UT-#M6I..,.-+^@_?W@^?+%W</3!O-V+Z-Y;X'H)CCQ
M2;$0?(B#^ ]@])_VSR\Z2PYZ(T?_%[GWTQ_$O9]^DWKB"_T5$)(H_SG3_P-0
M2P$"% ,4    "  *2(Q5)7.PNGP#   Q#@  $0              @ $
M8V5V82TR,#(R,3(P-RYX<V102P$"% ,4    "  *2(Q5TJRW+-X$  !3+0
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M,C(Q,C Y7SAK+FAT;5!+ 0(4 Q0    (  I(C%5BD^D\OS$  /3R   -
M          "  >4N  !E>%\T-34Q-S<N:'1M4$L! A0#%     @ "TB,56%2
M_23/20  0=@!  T              ( !SV   &5X7S0U-3$W."YH=&U02P$"
M% ,4    "  +2(Q5'Z-FCS<7  #;BP  #0              @ ')J@  97A?
M-#4U,3<Y+FAT;5!+ 0(4 Q0    (  M(C%5COOA6BP\  -4T   -
M      "  2O"  !E>%\T-34Q.# N:'1M4$L%!@     )  D -0(  .'1
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
